<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Med Virol</journal-id><journal-id journal-id-type="iso-abbrev">Rev. Med. Virol</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1099-1654</journal-id><journal-id journal-id-type="publisher-id">RMV</journal-id><journal-title-group><journal-title>Reviews in Medical Virology</journal-title></journal-title-group><issn pub-type="ppub">1052-9276</issn><issn pub-type="epub">1099-1654</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7235496</article-id><article-id pub-id-type="doi">10.1002/rmv.2106</article-id><article-id pub-id-type="publisher-id">RMV2106</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Reviews</subject></subj-group></article-categories><title-group><article-title>Laboratory testing of SARS&#x02010;CoV, MERS&#x02010;CoV, and SARS&#x02010;CoV&#x02010;2 (2019&#x02010;nCoV): Current status, challenges, and countermeasures</article-title><alt-title alt-title-type="left-running-head">Yan et al.</alt-title></title-group><contrib-group><contrib id="rmv2106-cr-0001" contrib-type="author"><name><surname>Yan</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="rmv2106-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="rmv2106-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="rmv2106-cr-0002" contrib-type="author"><name><surname>Chang</surname><given-names>Le</given-names></name><xref ref-type="aff" rid="rmv2106-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="rmv2106-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="rmv2106-cr-0003" contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Lunan</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3163-7891</contrib-id><xref ref-type="aff" rid="rmv2106-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="rmv2106-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="rmv2106-aff-0003">
<sup>3</sup>
</xref><address><email>lunan99@163.com</email></address></contrib></contrib-group><aff id="rmv2106-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology</named-content>
<institution>Institute of Geriatric Medicine, Chinese Academy of Medical Sciences</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="rmv2106-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Beijing Engineering Research Center of Laboratory Medicine</named-content>
<institution>Beijing Hospital</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="rmv2106-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Graduate School, Peking Union Medical College</named-content>
<institution>Chinese Academy of Medical Sciences</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Lunan Wang, No.1 Dahua Road, Beijing 100730, China.<break/>
Email: <email>lunan99@163.com</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>4</month><year>2020</year></pub-date><pub-date pub-type="ppub"><month>5</month><year>2020</year></pub-date><volume>30</volume><issue>3</issue><issue-id pub-id-type="doi">10.1002/rmv.v30.3</issue-id><elocation-id>e2106</elocation-id><history><date date-type="received"><day>02</day><month>3</month><year>2020</year></date><date date-type="rev-recd"><day>20</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>20</day><month>3</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 John Wiley & Sons, Ltd. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2020 John Wiley &#x00026; Sons, Ltd</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:RMV-30-e2106.pdf"/><abstract><title>Summary</title><p>Emerging and reemerging infectious diseases are global public concerns. With the outbreak of unknown pneumonia in Wuhan, China in December 2019, a new coronavirus, SARS&#x02010;CoV&#x02010;2 has been attracting tremendous attention. Rapid and accurate laboratory testing of SARS&#x02010;CoV&#x02010;2 is essential for early discovery, early reporting, early quarantine, early treatment, and cutting off epidemic transmission. The genome structure, transmission, and pathogenesis of SARS&#x02010;CoV&#x02010;2 are basically similar to SARS&#x02010;CoV and MERS&#x02010;CoV, the other two beta&#x02010;CoVs of medical importance. During the SARS&#x02010;CoV and MERS&#x02010;CoV epidemics, a variety of molecular and serological diagnostic assays were established and should be referred to for SARS&#x02010;CoV&#x02010;2. In this review, by summarizing the articles and guidelines about specimen collection, nucleic acid tests (NAT) and serological tests for SARS&#x02010;CoV, MERS&#x02010;CoV, and SARS&#x02010;CoV&#x02010;2, several suggestions are put forward to improve the laboratory testing of SARS&#x02010;CoV&#x02010;2. In summary, for NAT: collecting stool and blood samples at later periods of illness to improve the positive rate if lower respiratory tract specimens are unavailable; increasing template volume to raise the sensitivity of detection; putting samples in reagents containing guanidine salt to inactivate virus as well as protect RNA; setting proper positive, negative and inhibition controls to ensure high&#x02010;quality results; simultaneously amplifying human RNase P gene to avoid false&#x02010;negative results. For antibody test, diverse assays targeting different antigens, and collecting paired samples are needed.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="rmv2106-kwd-0001">MERS&#x02010;CoV</kwd><kwd id="rmv2106-kwd-0002">nucleic acid testing</kwd><kwd id="rmv2106-kwd-0003">SARS&#x02010;CoV</kwd><kwd id="rmv2106-kwd-0004">SARS&#x02010;CoV&#x02010;2 (2019&#x02010;nCoV)</kwd><kwd id="rmv2106-kwd-0005">serological testing</kwd><kwd id="rmv2106-kwd-0006">specimen collection</kwd></kwd-group><counts><fig-count count="1"/><table-count count="5"/><page-count count="14"/><word-count count="10215"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2020</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.2 mode:remove_FC converted:19.05.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="rmv2106-cit-9001">
<string-name>
<surname>Yan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>. <article-title>Laboratory testing of SARS&#x02010;CoV, MERS&#x02010;CoV, and SARS&#x02010;CoV&#x02010;2 (2019&#x02010;nCoV): Current status, challenges, and countermeasures</article-title>. <source xml:lang="en">Rev Med Virol</source>. <year>2020</year>;<volume>30</volume>:<elocation-id>e2106</elocation-id>
<pub-id pub-id-type="doi">10.1002/rmv.2106</pub-id>
<pub-id pub-id-type="pmid">32302058</pub-id></mixed-citation>
</p></notes></front><body id="rmv2106-body-0001"><def-list list-content="abbreviations" id="rmv2106-lp-0001"><title>Abbreviations</title><def-item><term id="rmv2106-li-0001">+ssRNA</term><def id="rmv2106-li-0002"><p>single&#x02010;stranded positive&#x02010;sense RNA</p></def></def-item><def-item><term id="rmv2106-li-0003">ACE2</term><def id="rmv2106-li-0004"><p>angiotensin converting enzyme 2</p></def></def-item><def-item><term id="rmv2106-li-0005">CDC</term><def id="rmv2106-li-0006"><p>Centers for Disease Control and Prevention</p></def></def-item><def-item><term id="rmv2106-li-0007">CLIA</term><def id="rmv2106-li-0008"><p>chemiluminescence assay</p></def></def-item><def-item><term id="rmv2106-li-0009">CoV</term><def id="rmv2106-li-0010"><p>coronavirus</p></def></def-item><def-item><term id="rmv2106-li-0011">CRISPR</term><def id="rmv2106-li-0012"><p>clustered regularly interspaced short palindromic repeats</p></def></def-item><def-item><term id="rmv2106-li-0013">ELISA</term><def id="rmv2106-li-0014"><p>enzyme&#x02010;linked immunosorbent assay</p></def></def-item><def-item><term id="rmv2106-li-0015">FDA</term><def id="rmv2106-li-0016"><p>Food and Drug Administration</p></def></def-item><def-item><term id="rmv2106-li-0017">HDA</term><def id="rmv2106-li-0018"><p>helicase&#x02010;dependent amplification</p></def></def-item><def-item><term id="rmv2106-li-0019">ICU</term><def id="rmv2106-li-0020"><p>intensive care unit</p></def></def-item><def-item><term id="rmv2106-li-0021">IFA</term><def id="rmv2106-li-0022"><p>immunofluorescence assay</p></def></def-item><def-item><term id="rmv2106-li-0023">LAMP</term><def id="rmv2106-li-0024"><p>loop&#x02010;mediated isothermal amplification</p></def></def-item><def-item><term id="rmv2106-li-0025">LOD</term><def id="rmv2106-li-0026"><p>limit of detection</p></def></def-item><def-item><term id="rmv2106-li-0027">LRT</term><def id="rmv2106-li-0028"><p>lower respiratory tract</p></def></def-item><def-item><term id="rmv2106-li-0029">MERS&#x02010;CoV</term><def id="rmv2106-li-0030"><p>Middle East respiratory syndrome coronavirus</p></def></def-item><def-item><term id="rmv2106-li-0031">NASBA</term><def id="rmv2106-li-0032"><p>nucleic acid sequence&#x02010;based amplification</p></def></def-item><def-item><term id="rmv2106-li-0033">NAT</term><def id="rmv2106-li-0034"><p>nucleic acid tests</p></def></def-item><def-item><term id="rmv2106-li-0035">NP swab</term><def id="rmv2106-li-0036"><p>nasopharyngeal swab</p></def></def-item><def-item><term id="rmv2106-li-0037">NP</term><def id="rmv2106-li-0038"><p>nucleocapsid protein</p></def></def-item><def-item><term id="rmv2106-li-0039">OP swab</term><def id="rmv2106-li-0040"><p>oropharyngeal swab</p></def></def-item><def-item><term id="rmv2106-li-0041">POCT</term><def id="rmv2106-li-0042"><p>point of care testing</p></def></def-item><def-item><term id="rmv2106-li-0043">RCA</term><def id="rmv2106-li-0044"><p>rolling&#x02010;circle amplification</p></def></def-item><def-item><term id="rmv2106-li-0045">RdRp</term><def id="rmv2106-li-0046"><p>RNA&#x02010;dependent RNA polymerase</p></def></def-item><def-item><term id="rmv2106-li-0047">RPA</term><def id="rmv2106-li-0048"><p>isothermal recombinase polymerase amplification</p></def></def-item><def-item><term id="rmv2106-li-0049">rRT&#x02010;PCR</term><def id="rmv2106-li-0050"><p>real time reverse transcription&#x02010;polymerase chain reaction</p></def></def-item><def-item><term id="rmv2106-li-0051">SARS&#x02010;CoV</term><def id="rmv2106-li-0052"><p>severe acute respiratory syndrome coronavirus</p></def></def-item><def-item><term id="rmv2106-li-0053">SARSr&#x02010;CoV</term><def id="rmv2106-li-0054"><p>SARS&#x02010;related&#x02010;CoV</p></def></def-item><def-item><term id="rmv2106-li-0055">SDA</term><def id="rmv2106-li-0056"><p>strand displacement amplification</p></def></def-item><def-item><term id="rmv2106-li-0057">SHERLOCK</term><def id="rmv2106-li-0058"><p>Specific High Sensitivity Enzymatic Reporter UnLOCKing</p></def></def-item><def-item><term id="rmv2106-li-0059">TMA</term><def id="rmv2106-li-0060"><p>transcription&#x02010;mediated amplification</p></def></def-item><def-item><term id="rmv2106-li-0061">upE</term><def id="rmv2106-li-0062"><p>upstream of the E protein gene</p></def></def-item><def-item><term id="rmv2106-li-0063">URT</term><def id="rmv2106-li-0064"><p>upper respiratory tract</p></def></def-item><def-item><term id="rmv2106-li-0065">UTR</term><def id="rmv2106-li-0066"><p>untranslated region</p></def></def-item><def-item><term id="rmv2106-li-0067">VLPs</term><def id="rmv2106-li-0068"><p>virus&#x02010;like particles</p></def></def-item><def-item><term id="rmv2106-li-0069">WB</term><def id="rmv2106-li-0070"><p>western blot</p></def></def-item><def-item><term id="rmv2106-li-0071">WHO</term><def id="rmv2106-li-0072"><p>World Health Organization</p></def></def-item></def-list><sec id="rmv2106-sec-0001"><label>1</label><title>INTRODUCTION</title><p>In 2002 and 2003, severe acute respiratory syndrome coronavirus (SARS&#x02010;CoV) started in China and overspread in 29 countries worldwide, affecting more than 8000 people. Ten years later, Middle East respiratory syndrome coronavirus (MERS&#x02010;CoV) outbroke in Arabian Peninsula and overspread mainly in the Middle East, affecting more than 2000 people.<xref rid="rmv2106-bib-0001" ref-type="ref">
<sup>1</sup>
</xref> These two outbreaks demonstrated the high transmissibility and pathogenicity of emerging coronaviruses (CoVs). Since late December 2019, pneumonia of unknown cause that started in Wuhan, Hubei, China has been attracting tremendous attention. The pathogen of this unexplained pneumonia was isolated from human airway epithelial cells and identified as a novel CoV, named SARS&#x02010;CoV&#x02010;2.<xref rid="rmv2106-bib-0002" ref-type="ref">2</xref>, <xref rid="rmv2106-bib-0003" ref-type="ref">3</xref> The World Health Organization (WHO) has declared the SARS&#x02010;CoV&#x02010;2 a public health emergency of international concern on 5 February 2020 and more recently, a pandemic. By 18 March 2020, WHO confirmed a total of 191&#x02009;127 cases of SARS&#x02010;CoV&#x02010;2 infection and 7807 deaths worldwide. Among them, 91&#x02009;845 confirmed cases were distributed in Western Pacific region and 74&#x02009;760 were in European region.<xref rid="rmv2106-bib-0004" ref-type="ref">
<sup>4</sup>
</xref> Rapid and accurate diagnosis of the causative viral pathogen is essential for early discovery, early reporting, early quarantine, early treatment, and cutting off epidemic transmission.</p></sec><sec id="rmv2106-sec-0002"><label>2</label><title>OVERVIEW OF CORONAVIRUSES</title><p>CoVs are enveloped single&#x02010;stranded positive&#x02010;sense RNA (+ssRNA) viruses that can infect respiratory, gastrointestinal, hepatic, central nervous systems of humans, other mammals and birds.<xref rid="rmv2106-bib-0005" ref-type="ref">
<sup>5</sup>
</xref> CoVs belong to the subfamily <italic>Coronavirinae</italic> in the family <italic>Coronaviridae</italic>.<xref rid="rmv2106-bib-0006" ref-type="ref">
<sup>6</sup>
</xref> This subfamily consists of four genera&#x02010;alpha, beta, gamma, and delta&#x02010;CoVs.<xref rid="rmv2106-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> Seven CoVs are known to cause respiratory diseases in humans. Among them, Alpha&#x02010;CoVs HCoV&#x02010;NL63, HCoV&#x02010;229E, and beta&#x02010;CoVs HCoV&#x02010;OC43, HKU1 can induce mild upper respiratory disease in immunocompetent individuals, while the other three CoVs SARS&#x02010;CoV, MERS&#x02010;CoV, and SARS&#x02010;CoV&#x02010;2 belonging to beta&#x02010;CoVs are more pathogenic.<xref rid="rmv2106-bib-0006" ref-type="ref">6</xref>, <xref rid="rmv2106-bib-0008" ref-type="ref">8</xref> The genome of a typical CoV contains a 5&#x02032; untranslated region (UTR), a conserved replicase domain (ORF 1ab), four genes S, E, M, and N to encode structural proteins spike, envelope, membrane, and nucleocapsid proteins, a 3&#x02032; UTR, and several unidentified nonstructural ORFs (Figure <xref rid="rmv2106-fig-0001" ref-type="fig">1</xref>).<xref rid="rmv2106-bib-0006" ref-type="ref">6</xref>, <xref rid="rmv2106-bib-0009" ref-type="ref">9</xref>
</p><fig fig-type="FIGURE" xml:lang="en" id="rmv2106-fig-0001" orientation="portrait" position="float"><label>FIGURE 1</label><caption><p>Genome structures of SARS&#x02010;CoV, MERS&#x02010;CoV, and SARS&#x02010;CoV&#x02010;2. All three CoVs contain a conserved replicase domain (ORF 1ab) (blue). The structural genes (green) S, E, M and N are common features to all CoVs, they encode the structural proteins spike, envelope, membrane, and nucleocapsid, respectively. The accessory genes (orange) are unique to different CoVs</p></caption><graphic id="nlm-graphic-1" xlink:href="RMV-30-e2106-g001"/></fig><p>Person&#x02010;to&#x02010;person spread of SARS&#x02010;CoV, MERS&#x02010;CoV, and SARS&#x02010;CoV&#x02010;2 mainly occurs via respiratory droplets produced when an infect person coughs or sneezes.<xref rid="rmv2106-bib-0010" ref-type="ref">
<sup>10</sup>
</xref> Fever was the most prevalent symptom that occurred in 86% to 97% SARS&#x02010;CoV&#x02010;2 infected patients, followed by dry cough (59%&#x02010;76%), fatigue (34&#x02010;68%), and dyspnea (20%&#x02010;40%).<xref rid="rmv2106-bib-0011" ref-type="ref">
<sup>11</sup>
</xref> The median time from first symptom to dyspnea was only 5&#x02009;days.<xref rid="rmv2106-bib-0012" ref-type="ref">
<sup>12</sup>
</xref> Apart from acute respiratory syndrome, some other organ dysfunctions, including gastrointestinal symptoms, hepatic dysfunction, splenic atrophy, seizures, and lymphadenopathy have been found in SARS and MERS.<xref rid="rmv2106-bib-0013" ref-type="ref">13</xref>, <xref rid="rmv2106-bib-0014" ref-type="ref">14</xref>, <xref rid="rmv2106-bib-0015" ref-type="ref">15</xref>, <xref rid="rmv2106-bib-0016" ref-type="ref">16</xref> Since SARS&#x02010;CoV&#x02010;2 shares the same receptor angiotensin converting enzyme 2 (ACE2) with SARS&#x02010;CoV,<xref rid="rmv2106-bib-0017" ref-type="ref">17</xref>, <xref rid="rmv2106-bib-0018" ref-type="ref">18</xref> it is reasonable to speculate that these organ dysfunctions may also be found in SARS&#x02010;CoV&#x02010;2 infected patients. Actually, a retrospective, observational study showed that in 52 critically ill adult patients who were admitted to the intensive care unit (ICU), 15 (29%) had acute kidney injury, 12 (23%) cardiac injury, and 15 (29%) liver dysfunction.<xref rid="rmv2106-bib-0019" ref-type="ref">
<sup>19</sup>
</xref> The most severe sequelae after rehabilitation from SARS were femoral head necrosis and pulmonary fibrosis. High&#x02010;dose steroid pulse treatment was used to suppress inflammation, which caused subchondral osteonecrosis in about 5% of SARS patients.<xref rid="rmv2106-bib-0020" ref-type="ref">
<sup>20</sup>
</xref> The risk of osteonecrosis was 0.6% for patients receiving less than 3 g and 13% for patients receiving more than 3 g prednisolone&#x02010;equivalent dose.<xref rid="rmv2106-bib-0020" ref-type="ref">
<sup>20</sup>
</xref> In addition, the use of high dose of hydrocortisone or methylprednisolone for an extended duration was shown to be a significant risk factor for osteonecrosis.<xref rid="rmv2106-bib-0021" ref-type="ref">
<sup>21</sup>
</xref> In order to suppress inflammation without causing osteonecrosis in SARS&#x02010;CoV&#x02010;2 infected patients, Chinese National Health Commission recommended that glucocorticoid should be used in a short period (3&#x02010;5&#x02009;days) as appropriate, and the dose should not exceed 1 to 2 mg/kg/d of methylprednisolone.<xref rid="rmv2106-bib-0022" ref-type="ref">
<sup>22</sup>
</xref> Moreover, it should be considered that glucocorticoid treatment could delay clearance of viral RNA because of immunosuppression.</p><sec id="rmv2106-sec-0003"><label>2.1</label><title>Specimens</title><p>Appropriate specimen collection and processing is the first and very important step for laboratory diagnosis. Specimen types of patients with respiratory virus infection are diverse. Viral RNA could be detected in upper respiratory tract (URT), lower respiratory tract (LRT), stool, blood, and urine of SARS&#x02010;CoV, MERS&#x02010;CoV, and SARS&#x02010;CoV&#x02010;2 infected persons. Among them, URT specimens, as well as available LRT specimens in severely affected patients must be collected for diagnosis and should be tested repeatedly if the first testing is negative in patients with epidemiological history and suspected symptoms of SARS&#x02010;CoV&#x02010;2 infection. It was reported that SARS&#x02010;CoV&#x02010;2 RNA could be detected in stool, blood, or urine even if it could not be detected in URT specimens,<xref rid="rmv2106-bib-0023" ref-type="ref">23</xref>, <xref rid="rmv2106-bib-0024" ref-type="ref">24</xref> so collecting stool, blood or urine samples if condition permits is helpful to improve positive rate when LRT specimens are unavailable. To demonstrate viral clearance during treatment, samples should also be collected and tested repeatedly. WHO recommended that the frequency of specimen collection should be at least every 2 to 4&#x02009;days until there are two consecutive negative results in a clinically recovered patient at least 24&#x02009;hours apart.<xref rid="rmv2106-bib-0025" ref-type="ref">
<sup>25</sup>
</xref> Also, Chinese National Health Commission and the US Centers for Disease Control and Prevention (CDC) recommended that negative results of real time reverse transcription&#x02010;polymerase chain reaction (rRT&#x02010;PCR) testing for SARS&#x02010;CoV&#x02010;2 from at least two sequential respiratory tract specimens collected at least 24&#x02009;hours apart can be considered to discontinue transmission&#x02010;based precautions.<xref rid="rmv2106-bib-0025" ref-type="ref">25</xref>, <xref rid="rmv2106-bib-0026" ref-type="ref">26</xref>
</p><p>The quality of specimens can be affected by several steps including operation of specimen collection, transport, and storage. For URT and sputum samples, sample quality depends greatly on the operation of the collectors. Firstly, synthetic fiber swabs with plastic shafts and sterile container were recommended to use when collecting, while calcium alginate swabs or swabs with wooden shafts should not be used as they may contain substances that inactivate viruses and inhibit PCR testing.<xref rid="rmv2106-bib-0027" ref-type="ref">
<sup>27</sup>
</xref> Secondly, to get enough virus infected cells, swabs must be inserted deep enough. In detail, nasopharyngeal (NP) swab must be inserted through the nares parallel to the palate, and oropharyngeal (OP) swab needs to be inserted into posterior pharynx and tonsillar areas.<xref rid="rmv2106-bib-0028" ref-type="ref">28</xref>, <xref rid="rmv2106-bib-0029" ref-type="ref">29</xref> Several studies have reported that combined NP and OP specimens could increase the sensitivity of detecting respiratory viruses.<xref rid="rmv2106-bib-0030" ref-type="ref">30</xref>, <xref rid="rmv2106-bib-0031" ref-type="ref">31</xref>, <xref rid="rmv2106-bib-0032" ref-type="ref">32</xref> As seen in Table <xref rid="rmv2106-tbl-0001" ref-type="table">1</xref>, although using different RT&#x02010;PCR methods targeting different genes, the threshold cycle (CT) value of NP and OP swabs was much lower than NP or OP swab alone, suggesting that in accordance with other respiratory viruses, combining NP and OP swabs together could increase viral load and the sensitivity of SARS&#x02010;CoV&#x02010;2 RNA detection. Sputum is often confused with saliva. Although SARS&#x02010;CoV&#x02010;2 could be detected in saliva,<xref rid="rmv2106-bib-0033" ref-type="ref">
<sup>33</sup>
</xref> sputum is preferred by several guidelines.<xref rid="rmv2106-bib-0027" ref-type="ref">27</xref>, <xref rid="rmv2106-bib-0029" ref-type="ref">29</xref>, <xref rid="rmv2106-bib-0034" ref-type="ref">34</xref> Patients should cough deeply so that sputum rather than oral secretions is collected. Dehydration may lessen the fluid in the lungs and make it hard to produce sputum, hence drinking water before collection can increase availability. To avoid contamination, all types of samples must be transported in sterile containers. To ensure sample stability, storage condition should be strictly controlled, which is summarized with other key points of specimen collection in Table <xref rid="rmv2106-tbl-0002" ref-type="table">2</xref>.</p><table-wrap id="rmv2106-tbl-0001" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 1</label><caption><p>Viral kinetics (CT value or log10 copies/mL) of SARS&#x02010;CoV&#x02010;2 in respiratory specimens</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th rowspan="2" style="border-bottom:solid 1px #000000" align="left" valign="bottom" colspan="1">Days of illness</th><th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">NP swab</th><th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">OP swab</th><th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">NP and OP swabs<xref rid="rmv2106-bib-0046" ref-type="ref">
<sup>46</sup>
</xref>
</th><th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">sputum<xref rid="rmv2106-bib-0046" ref-type="ref">
<sup>46</sup>
</xref>
</th><th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Saliva<xref rid="rmv2106-bib-0033" ref-type="ref">
<sup>33</sup>
</xref> Log10 copies/mL</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">n = 17<xref rid="rmv2106-bib-0110" ref-type="ref">
<sup>110</sup>
</xref>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">n = 1<xref rid="rmv2106-bib-0111" ref-type="ref">
<sup>111</sup>
</xref>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">n = 17<xref rid="rmv2106-bib-0110" ref-type="ref">
<sup>110</sup>
</xref>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">n = 1<xref rid="rmv2106-bib-0111" ref-type="ref">
<sup>111</sup>
</xref>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">n = 1</th><th align="left" valign="bottom" rowspan="1" colspan="1">n = 1</th><th align="left" valign="bottom" rowspan="1" colspan="1">n = 1</th><th align="left" valign="bottom" rowspan="1" colspan="1">n = 1</th><th align="left" valign="bottom" rowspan="1" colspan="1">n = 12</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">31</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">26</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">5.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">6.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">21</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">25.05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">6.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">32</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">34</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">28.33</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">27.52</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">6.15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">32</td><td align="left" valign="top" rowspan="1" colspan="1">18&#x02014;20</td><td align="left" valign="top" rowspan="1" colspan="1">36</td><td align="left" valign="top" rowspan="1" colspan="1">21&#x02014;22</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">6.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">27</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">35</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">32.15</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">22.05</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">2.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">36</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">28.26</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">30.99</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">4.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">34</td><td align="left" valign="top" rowspan="1" colspan="1">23&#x02013;24</td><td align="left" valign="top" rowspan="1" colspan="1">36</td><td align="left" valign="top" rowspan="1" colspan="1">32&#x02014;33</td><td align="left" valign="top" rowspan="1" colspan="1">28.56</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">24.92</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">35</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">29.66</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">27.36</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">2.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">30.38</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">36</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">39</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">33.4</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">29.7</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">11</td><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">33&#x02014;34</td><td align="left" valign="top" rowspan="1" colspan="1">34</td><td align="left" valign="top" rowspan="1" colspan="1">36&#x02014;40</td><td align="left" valign="top" rowspan="1" colspan="1">35.09</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">29.96</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">37</td><td align="left" valign="top" rowspan="1" colspan="1">37&#x02014;40</td><td align="left" valign="top" rowspan="1" colspan="1">39</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">32.2</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">32.5</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="left" valign="top" rowspan="1" colspan="1">36</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">37</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">32.63</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">36</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">33.27</td><td align="left" valign="top" rowspan="1" colspan="1">35.43</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">32.29</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">39</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">39</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">26.89</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">17</td><td align="left" valign="top" rowspan="1" colspan="1">39</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">32.61</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">19</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">21</td><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">22</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">23</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">24</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">25</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">36.69</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">26</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="left" valign="top" rowspan="1" colspan="1">ud</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr></tbody></table><table-wrap-foot id="rmv2106-ntgp-0001"><fn id="rmv2106-note-0001"><p>
<italic>Note:</italic> Reference <xref rid="rmv2106-bib-0110" ref-type="ref">110</xref> targets N and ORF1b gene, Reference <xref rid="rmv2106-bib-0111" ref-type="ref">111</xref> targets N gene. Reference <xref rid="rmv2106-bib-0046" ref-type="ref">46</xref> targets RdRp gene and E gene, while only the results of RdRp gene are summarized in this table. Reference <xref rid="rmv2106-bib-0033" ref-type="ref">33</xref> targets S gene. Raw data were not published in References <xref rid="rmv2106-bib-0110" ref-type="ref">110</xref> and <xref rid="rmv2106-bib-0033" ref-type="ref">33</xref>, so the CT values and viral loads are estimated from figures. The finding of undetectable in swabs in between CT values of 26.89 and 32.61 might be caused by the poor quality of specimen collected in D16, which was not discussed in the original article. Time indicated in Reference <xref rid="rmv2106-bib-0033" ref-type="ref">33</xref> is the time after hospitalization.</p></fn><fn id="rmv2106-note-0002"><p>Abbreviations: NP swab, nasopharyngeal swab; OP swab, oropharyngeal swab; ud, undetected.</p></fn></table-wrap-foot></table-wrap><table-wrap id="rmv2106-tbl-0002" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 2</label><caption><p>Key points of specimen collection</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Specimen type</th><th align="left" valign="bottom" rowspan="1" colspan="1">Purpose of collection</th><th align="left" valign="bottom" rowspan="1" colspan="1">Collection materials</th><th align="left" valign="bottom" rowspan="1" colspan="1">Transport and storage</th><th align="left" valign="bottom" rowspan="1" colspan="1">Guarantee of sample stability, and inactivation without influencing NAT test</th><th align="left" valign="bottom" rowspan="1" colspan="1">Avoid false negative results of NAT caused by specimen quality</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Nasopharyngeal and oropharyngeal swabs</td><td align="left" valign="top" rowspan="1" colspan="1">Collect for diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1">Synthetic fiber swabs with plastic shafts, sterile container</td><td rowspan="8" align="left" valign="top" colspan="1">
<p>1. If could test in 24&#x02009;hours, store at 4&#x000b0;C. Otherwise store at &#x02212;70&#x000b0;C</p>
<p>2. Serum could be store at 4&#x000b0;C for 3&#x02009;days, and stored at &#x02264;&#x02212;20&#x000b0;C for long&#x02010;stem preservation</p>
<p>3. If long&#x02010;distance transport is required, use dry ice or other refrigeration methods</p>
<p>4. Avoid repeated freezing and thawing</p>
</td><td rowspan="8" align="left" valign="top" colspan="1">Virus retention medium containing guanidine salt</td><td rowspan="8" align="left" valign="top" colspan="1">
<p>1. Set positive, negative, and inhibition control when extraction and amplification</p>
<p>2. Test human RNase P gene simultaneously</p>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sputum</td><td align="left" valign="top" rowspan="1" colspan="1">Collect for diagnosis if produced</td><td align="left" valign="top" rowspan="1" colspan="1">Sterile container</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Bronchoalveolar lavage</td><td rowspan="2" align="left" valign="top" colspan="1">Collect in severe patients for diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1">Sterile container</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Endotracheal aspirate, and nasopharyngeal aspirate</td><td align="left" valign="top" rowspan="1" colspan="1">Sterile container</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Blood</td><td align="left" valign="top" rowspan="1" colspan="1">NAT test for improve diagnosis rate, monitor viremia, epidemiological surveillance</td><td align="left" valign="top" rowspan="1" colspan="1">Vacuum blood collection tubes with EDTA anticoagulant</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum</td><td align="left" valign="top" rowspan="1" colspan="1">Collect 2 samples acute and convalescent for antibody test to monitor seroconversion, epidemiological surveillance</td><td align="left" valign="top" rowspan="1" colspan="1">Anticoagulant&#x02010;free blood collection vacuum tubes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Stool</td><td align="left" valign="top" rowspan="1" colspan="1">Improve diagnosis rate when LRT specimens are unavailable</td><td align="left" valign="top" rowspan="1" colspan="1">Sterile container</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Urine</td><td align="left" valign="top" rowspan="1" colspan="1">Improve diagnosis rate when LRT specimens are unavailable</td><td align="left" valign="top" rowspan="1" colspan="1">Sterile container</td></tr></tbody></table><table-wrap-foot id="rmv2106-ntgp-0002"><fn id="rmv2106-note-0003"><p>
<italic>Note:</italic> &#x0201c;Collection materials&#x0201d; and &#x0201c;Transport and storage&#x0201d; reference the guidelines of 2019&#x02010;nCoV laboratory testing delivered by WHO and Chinese National Health Commission.<xref rid="rmv2106-bib-0029" ref-type="ref">29</xref>, <xref rid="rmv2106-bib-0034" ref-type="ref">34</xref>
</p></fn><fn id="rmv2106-note-0004"><p>Abbreviation: LRT, lower respiratory tract.</p></fn></table-wrap-foot></table-wrap><p>After specimen collection, different methods should be used to process specimens for different purposes. For isolation and culture of virus, centrifuging samples to remove cellular debris, and then inoculating the supernatant on human airway epithelial cells, Vero E6 cells or Huh&#x02010;7 cells. It took about 96&#x02009;hours for SARS&#x02010;CoV&#x02010;2 to be successfully cultured in human airway epithelial cells, and took about 6&#x02009;days to be cultured in Vero E6 or Huh&#x02010;7 cells.<xref rid="rmv2106-bib-0010" ref-type="ref">10</xref>, <xref rid="rmv2106-bib-0022" ref-type="ref">22</xref> The isolation and culture should be conducted at BSL&#x02010;3, and laboratory workers should wear protective equipment, including disposable gloves, solid front or wrap&#x02010;around gowns, scrub suits, or coveralls with sleeves that fully cover the forearms, head coverings, shoe covers or dedicated shoes, eye protection, and respiratory protection.<xref rid="rmv2106-bib-0035" ref-type="ref">
<sup>35</sup>
</xref> Inactivation of viruses without reducing detection efficiency is required for testing RNA of high pathogenic CoVs at BSL&#x02010;2 and protecting experimenters from infection. Trizol, Trizol LS (Life Technologies), and buffer AVL (Qiagen) have been standard methodology for purifying and extracting viral RNA for years. Guanidine salt in these agents can inhibit nuclease, thereby ensuring viral RNA is not degraded. Viral RNA in samples placed in buffer AVL was stable for at least 48&#x02009;hours at 32&#x000b0;C, and at least 35&#x02009;days at either 4&#x000b0;C or &#x02212;20&#x000b0;C.<xref rid="rmv2106-bib-0036" ref-type="ref">
<sup>36</sup>
</xref> In addition, the powerful denaturing activity of guanidine isothiocyanate in these reagents could denature and dissolve protein, thus effectively inactivating enveloped viruses. The phenol component of Trizol could also disrupt membranes and denature proteins. These reagents were shown to inactivate alphaviruses, flaviviruses, filoviruses, bunyaviruses, and ebola virus.<xref rid="rmv2106-bib-0037" ref-type="ref">37</xref>, <xref rid="rmv2106-bib-0038" ref-type="ref">38</xref>, <xref rid="rmv2106-bib-0039" ref-type="ref">39</xref> Kumar, et al. confirmed that AVL, Trizol and Trizol LS could completely inactivate MERS&#x02010;CoV within 10 minutes' room temperature incubation.<xref rid="rmv2106-bib-0040" ref-type="ref">
<sup>40</sup>
</xref> Thus, although many methods have been verified to effectively inactivate SARS&#x02010;CoV and MERS&#x02010;CoV,<xref rid="rmv2106-bib-0041" ref-type="ref">
<sup>41</sup>
</xref> we suggest handling samples in these reagents, as well as other virus retention reagents containing guanidine salt would be an effective way to inactivate and stabilize viruses, without affecting subsequent molecular testing of SARS&#x02010;CoV&#x02010;2. Since CoVs are sensitive to heat, heating inactivation of samples could effectively inactive virus if SARS&#x02010;CoV&#x02010;2 antibody needs to be tested at BSL&#x02010;2. However, it should be noticed that heat inactivation could significantly interfere with the levels of antibodies, and might cause false&#x02010;negative results. It was reported that the anti&#x02010;SARS&#x02010;CoV&#x02010;2 IgM levels of all samples decreased by an average level of 53.56%, and the IgG levels were decreased in 64.71% samples by an average level of 49.54% after heating at 56&#x000b0;C for 30&#x02009;minutes.<xref rid="rmv2106-bib-0042" ref-type="ref">
<sup>42</sup>
</xref>
</p><p>It has been reported that viral loads of SARS&#x02010;CoV and MERS&#x02010;CoV in respiratory specimens always peak in the second week after symptom onset, and viral loads in LRT specimens were higher than in URT specimens.<xref rid="rmv2106-bib-0043" ref-type="ref">43</xref>, <xref rid="rmv2106-bib-0044" ref-type="ref">44</xref>, <xref rid="rmv2106-bib-0045" ref-type="ref">45</xref> As seen in Table <xref rid="rmv2106-tbl-0003" ref-type="table">3</xref>, positive rate of SARS&#x02010;CoV and MERS&#x02010;CoV RNA in LRT specimens was about 100% at the first 2&#x02009;weeks of illness, while it remained relatively lower in URT specimens. So that LRT specimens are preferred to test if available. Now, several studies have shown the viral kinetics of SARS&#x02010;CoV&#x02010;2 in respiratory specimens. Zhang, et al. reported that only 50% of OP swabs were positive with a CT value of 32.1 (30.9&#x02010;32.75) at first sampling after symptom, while after 5&#x02009;days, only 25% of oral swabs were positive with a CT value of 26.95 (25.98&#x02010;27.75).<xref rid="rmv2106-bib-0023" ref-type="ref">
<sup>23</sup>
</xref> As seen in Tables <xref rid="rmv2106-tbl-0001" ref-type="table">1</xref> and <xref rid="rmv2106-tbl-0003" ref-type="table">3</xref>, differently to SARS&#x02010;CoV and MERS&#x02010;CoV, SARS&#x02010;CoV&#x02010;2 viral loads in respiratory specimens often peak in the first week of illness and decrease thereafter.</p><table-wrap id="rmv2106-tbl-0003" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 3</label><caption><p>Viral kinetics of SARS&#x02010;CoV, MERS&#x02010;CoV, and SARS&#x02010;CoV&#x02010;2</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Sample type</th><th align="left" valign="bottom" rowspan="1" colspan="1">Time of illness</th><th align="left" valign="bottom" rowspan="1" colspan="1">SARS&#x02010;CoV</th><th align="left" valign="bottom" rowspan="1" colspan="1">MERS&#x02010;CoV</th><th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">SARS&#x02010;CoV&#x02010;2</th></tr></thead><tbody valign="top"><tr><td rowspan="3" align="left" valign="top" colspan="1">URT</td><td align="left" valign="top" rowspan="1" colspan="1">Week 1</td><td align="left" valign="top" rowspan="1" colspan="1">32%, 5.36<sup>&#x02460;</sup>
<xref rid="rmv2106-bib-0043" ref-type="ref">
<sup>43</sup>
</xref>; 58%, 4.18<sup>&#x02460;</sup>
<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>; 39%<sup>&#x02461;</sup>
<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">75.5%, 4.5<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>; 25%, 5<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>; 33.3%, 5<sup>&#x02464;</sup>
<xref rid="rmv2106-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>
</td><td colspan="2" align="left" valign="top" rowspan="1">5.3<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0052" ref-type="ref">
<sup>52</sup>
</xref>; 31.5 CT<sup>&#x02464;</sup>
<xref rid="rmv2106-bib-0110" ref-type="ref">
<sup>110</sup>
</xref>; 36 CT<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0110" ref-type="ref">
<sup>110</sup>
</xref> 50%, 32.1 CT<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0023" ref-type="ref">
<sup>23</sup>
</xref>; 100%, 30.5 CT<sup>&#x02464;</sup>
<xref rid="rmv2106-bib-0112" ref-type="ref">
<sup>112</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Week 2</td><td align="left" valign="top" rowspan="1" colspan="1">68%, 7.28<sup>&#x02460;</sup>
<xref rid="rmv2106-bib-0043" ref-type="ref">
<sup>43</sup>
</xref>; 60%, 5.25<sup>&#x02460;</sup>
<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>; 32%<sup>&#x02461;</sup>
<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>; 42.3%, 5.8<sup>&#x02460;</sup>
<xref rid="rmv2106-bib-0049" ref-type="ref">
<sup>49</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">45.8%, 3.5<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>; 88.2%, 5.5<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>; 23.5%, 4.5<sup>&#x02464;</sup>
<xref rid="rmv2106-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>
</td><td colspan="2" align="left" valign="top" rowspan="1">3.8<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0052" ref-type="ref">
<sup>52</sup>
</xref>; 37 CT<sup>&#x02464;</sup>
<xref rid="rmv2106-bib-0110" ref-type="ref">
<sup>110</sup>
</xref>; 38 CT<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0110" ref-type="ref">
<sup>110</sup>
</xref>; 25%, 31.65 CT<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0023" ref-type="ref">
<sup>23</sup>
</xref>; 94.4%, 31.95 CT<sup>&#x02464;</sup>
<xref rid="rmv2106-bib-0112" ref-type="ref">
<sup>112</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Week 3</td><td align="left" valign="top" rowspan="1" colspan="1">4.99<sup>&#x02460;</sup>
<xref rid="rmv2106-bib-0043" ref-type="ref">
<sup>43</sup>
</xref>; 39%, 4.77<sup>&#x02460;</sup>
<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>; 25%<sup>&#x02461;</sup>
<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>; 27.3%, 4.5<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>; 5.88%, 5.5<sup>&#x02464;</sup>
<xref rid="rmv2106-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>
</td><td colspan="2" align="left" valign="top" rowspan="1">40 CT<sup>&#x02464;</sup>
<xref rid="rmv2106-bib-0110" ref-type="ref">
<sup>110</sup>
</xref>; 38 CT<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0110" ref-type="ref">
<sup>110</sup>
</xref>; 69.2%, 33.05 CT<sup>&#x02464;</sup>
<xref rid="rmv2106-bib-0112" ref-type="ref">
<sup>112</sup>
</xref>
</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">LRT</td><td align="left" valign="top" rowspan="1" colspan="1">Week 1</td><td align="left" valign="top" rowspan="1" colspan="1">100%<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">100%, 8<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>; 100%, 6<sup>&#x02463;</sup>
<xref rid="rmv2106-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>
</td><td colspan="2" align="left" valign="top" rowspan="1">6.1<sup>&#x02465;</sup>
<xref rid="rmv2106-bib-0052" ref-type="ref">
<sup>52</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Week 2</td><td align="left" valign="top" rowspan="1" colspan="1">100%<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">93%, 7<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>; 100%, 6.8<sup>&#x02463;</sup>
<xref rid="rmv2106-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>
</td><td colspan="2" align="left" valign="top" rowspan="1">5.8<sup>&#x02465;</sup>
<xref rid="rmv2106-bib-0052" ref-type="ref">
<sup>52</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Week 3</td><td align="left" valign="top" rowspan="1" colspan="1">67%<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">66.7%, 5<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>; 100%, 6.3<sup>&#x02463;</sup>
<xref rid="rmv2106-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>
</td><td colspan="2" align="left" valign="top" rowspan="1">N/A</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">Stool</td><td align="left" valign="top" rowspan="1" colspan="1">Week 1</td><td align="left" valign="top" rowspan="1" colspan="1">47%, 6.52<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">16.7%, 4.5<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">25%, 31.65 CT<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0023" ref-type="ref">
<sup>23</sup>
</xref>; 75%, 28.2 CT<xref rid="rmv2106-bib-0112" ref-type="ref">
<sup>112</sup>
</xref>
</td><td rowspan="2" align="left" valign="top" colspan="1">53%, 2.74&#x02010;5.08<xref rid="rmv2106-bib-0052" ref-type="ref">
<sup>52</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Week 2</td><td align="left" valign="top" rowspan="1" colspan="1">97%<xref rid="rmv2106-bib-0043" ref-type="ref">
<sup>43</sup>
</xref>; 70%, 7.95<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>; 87.2%, 7.0<xref rid="rmv2106-bib-0049" ref-type="ref">
<sup>49</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">14.3%, 4<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">37.5%, 26.5 CT<sup>&#x02462;</sup>
<xref rid="rmv2106-bib-0023" ref-type="ref">
<sup>23</sup>
</xref>; 42.9%, 30.3 CT<xref rid="rmv2106-bib-0112" ref-type="ref">
<sup>112</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Week 3</td><td align="left" valign="top" rowspan="1" colspan="1">54%, 5.33<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>
</td><td colspan="2" align="left" valign="top" rowspan="1">N/A</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">Blood</td><td align="left" valign="top" rowspan="1" colspan="1">Week 1</td><td align="left" valign="top" rowspan="1" colspan="1">33%<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>; 50%, 2.37<xref rid="rmv2106-bib-0053" ref-type="ref">
<sup>53</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">48.1%, 4<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>; 10%, 4.8<xref rid="rmv2106-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0<xref rid="rmv2106-bib-0112" ref-type="ref">
<sup>112</sup>
</xref>
</td><td rowspan="2" align="left" valign="top" colspan="1">40%<xref rid="rmv2106-bib-0023" ref-type="ref">
<sup>23</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Week 2</td><td align="left" valign="top" rowspan="1" colspan="1">25%<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>; 50%, 2.59<xref rid="rmv2106-bib-0053" ref-type="ref">
<sup>53</sup>
</xref> 41.5%, 2.7<xref rid="rmv2106-bib-0049" ref-type="ref">
<sup>49</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">25%, 3<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>; 29.4%, 4.2<xref rid="rmv2106-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">25%, 33.15 CT<xref rid="rmv2106-bib-0112" ref-type="ref">
<sup>112</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Week 3</td><td align="left" valign="top" rowspan="1" colspan="1">33%<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>; 25%, 2.18<xref rid="rmv2106-bib-0053" ref-type="ref">
<sup>53</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>; 17.6%, 4.7<xref rid="rmv2106-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>
</td><td colspan="2" align="left" valign="top" rowspan="1">N/A</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">Urine</td><td align="left" valign="top" rowspan="1" colspan="1">Week 1</td><td align="left" valign="top" rowspan="1" colspan="1">33%<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">9%, 2<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>
</td><td rowspan="3" colspan="2" align="left" valign="top">0<xref rid="rmv2106-bib-0112" ref-type="ref">
<sup>112</sup>
</xref>; 6.9%<xref rid="rmv2106-bib-0024" ref-type="ref">
<sup>24</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Week 2</td><td align="left" valign="top" rowspan="1" colspan="1">25%<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref> 28.8%, 4.4<xref rid="rmv2106-bib-0049" ref-type="ref">
<sup>49</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Week 3</td><td align="left" valign="top" rowspan="1" colspan="1">14%<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>
</td></tr></tbody></table><table-wrap-foot id="rmv2106-ntgp-0003"><fn id="rmv2106-note-0005"><p>
<italic>Note:</italic> Data are expressed as &#x0201c;positive rate, viral load (log10 copies/mL or CT value),&#x0201d; which are converted directly from raw data or estimated from figures. Respiratory sample type:<sup>&#x02460;</sup>NP aspirates, <sup>&#x02461;</sup>Other URT specimens consisted of throat and nasal swabs, throat swabs, nasopharyngeal swabs, and nasal swabs, <sup>&#x02462;</sup>throat swabs, <sup>&#x02463;</sup>sputum or tracheal aspirate, <sup>&#x02464;</sup>nasopharyngeal swabs, <sup>&#x02465;</sup>Sputum. Time indicated in References <xref rid="rmv2106-bib-0051" ref-type="ref">51</xref> and <xref rid="rmv2106-bib-0023" ref-type="ref">23</xref> is the time of diagnosis, NOT the time of illness.</p></fn></table-wrap-foot></table-wrap><p>Evidence showed that viral RNA could be detected in blood and feces,<xref rid="rmv2106-bib-0033" ref-type="ref">33</xref>, <xref rid="rmv2106-bib-0046" ref-type="ref">46</xref> raising the possibilities of blood transmission and oral&#x02010;fecal transmission. A study of 2134 SARS&#x02010;CoV infected specimens showed that the rate of viral shedding in feces was low in the first 5&#x02009;days of illness (up to 28%), but rose gradually to peak at around 70% at 9 to 14&#x02009;days with very high titers, even higher than in nasopharyngeal aspirates.<xref rid="rmv2106-bib-0044" ref-type="ref">
<sup>44</sup>
</xref> Other studies also showed that the positive rate for stool specimens peaked at Weeks 2 and 3, with a higher diagnostic yield than pooled throat and nasal swabs, and nasopharyngeal aspirate specimens.<xref rid="rmv2106-bib-0047" ref-type="ref">47</xref>, <xref rid="rmv2106-bib-0048" ref-type="ref">48</xref>, <xref rid="rmv2106-bib-0049" ref-type="ref">49</xref> MERS&#x02010;CoV was detectable in stools in the second week after illness.<xref rid="rmv2106-bib-0050" ref-type="ref">
<sup>50</sup>
</xref> Different from SARS&#x02010;CoV, only 14.6% of stool samples yielded viral RNA.<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref> Recently, viral RNA of SARS&#x02010;CoV&#x02010;2 was reported in stools, and the virus was isolated. The kinetics of viral loads in stools are still not very clear. Data showed that SARS&#x02010;CoV&#x02010;2 RNA can be detected in stools of 53% (9/17) confirmed cases at the first 2&#x02009;weeks of illness, with viral loads ranging from 550 to 1.21&#x02009;&#x000d7;&#x02009;10<sup>5</sup> copies/ml.<xref rid="rmv2106-bib-0052" ref-type="ref">
<sup>52</sup>
</xref> Another study showed that 25% SARS&#x02010;CoV&#x02010;2 infected patients had detectable viral RNA with a CT value of 31.65 (27.53&#x02010;33.23) in anal swabs at first sampling, while 5&#x02009;days later, 37.5% patients could test viral RNA positive in anal swabs with a CT value of 26.5 (24.22&#x02010;29.38).<xref rid="rmv2106-bib-0023" ref-type="ref">
<sup>23</sup>
</xref> More importantly, SARS&#x02010;CoV&#x02010;2 RNA can be found in anal swabs even if it cannot be detected in oral swabs.<xref rid="rmv2106-bib-0023" ref-type="ref">
<sup>23</sup>
</xref> Thus, it might be an optional way to improve the diagnosis rate of SARS&#x02010;CoV&#x02010;2 infection by testing stool samples when LRT specimens are unavailable.</p><p>Blood samples can be collected for both nucleic acid testing and serological testing. Testing of virus from blood samples could be an effective way to monitor viremia. SARS&#x02010;CoV RNA was detected in 50% of plasma and 78% of serum samples during the first week of illness.<xref rid="rmv2106-bib-0053" ref-type="ref">
<sup>53</sup>
</xref> High&#x02010;SARS&#x02010;CoV viral load in serum correlated with oxygen desaturation, mechanical ventilation, and death.<xref rid="rmv2106-bib-0049" ref-type="ref">
<sup>49</sup>
</xref> About 33% of serum samples yielded MERS&#x02010;CoV RNA at initial diagnosis, and were associated with a worse clinical course.<xref rid="rmv2106-bib-0051" ref-type="ref">51</xref>, <xref rid="rmv2106-bib-0054" ref-type="ref">54</xref> Patients with detectable SARS&#x02010;CoV&#x02010;2 RNA in the blood progressed to severe symptom stage, indicating a strong correlation of serum viral RNA with the disease severity.<xref rid="rmv2106-bib-0055" ref-type="ref">
<sup>55</sup>
</xref> In keeping with SARS&#x02010;CoV and MERS&#x02010;CoV,<xref rid="rmv2106-bib-0053" ref-type="ref">53</xref>, <xref rid="rmv2106-bib-0056" ref-type="ref">56</xref> plasma/serum SARS&#x02010;CoV&#x02010;2 quantification could also represent a potentially useful early diagnostic and prognostic tool.</p></sec><sec id="rmv2106-sec-0004"><label>2.2</label><title>Nucleic acid tests</title><p>Specific primers and standard operating procedures for nucleic acid tests (NAT) could be established as soon as the complete genome of the virus was sequenced, making NAT the optimal method for diagnosis. Current NAT tests for RNA viruses mainly include RT&#x02010;PCR, alternative isothermal amplification methods, and CRISPR&#x02010;Cas13a based Specific High Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK) system.<xref rid="rmv2106-bib-0057" ref-type="ref">
<sup>57</sup>
</xref>
</p><p>Due to its simplicity, easy methodology and extensively validated standard operating procedure, RT&#x02010;PCR is now the preferred and most widely used method for NAT. RT&#x02010;PCR assays targeting ORF 1a, ORF 1b, S gene, N gene of SARS&#x02010;CoV can detect &#x0003c;10 genome equivalents.<xref rid="rmv2106-bib-0058" ref-type="ref">58</xref>, <xref rid="rmv2106-bib-0059" ref-type="ref">59</xref> Assays targeting M gene and 3&#x02032;UTR also showed high sensitivity.<xref rid="rmv2106-bib-0060" ref-type="ref">60</xref>, <xref rid="rmv2106-bib-0061" ref-type="ref">61</xref> Three rRT&#x02010;PCR assays for routine detection of MERS&#x02010;CoV have been developed and recommended by WHO.<xref rid="rmv2106-bib-0062" ref-type="ref">
<sup>62</sup>
</xref> The primers target upstream of the E protein gene (upE), the ORF 1b, and the ORF 1a. Among them, sensitivity for upE target was 3.4 copies per reaction or 291 copies/mL of sample, which was considered highly sensitive and recommended for screening.<xref rid="rmv2106-bib-0063" ref-type="ref">
<sup>63</sup>
</xref> The ORF 1a assay was considered of equal sensitivity with the upE assay, while the ORF 1b assay was considered less sensitive than the ORF 1a assay.<xref rid="rmv2106-bib-0063" ref-type="ref">63</xref>, <xref rid="rmv2106-bib-0064" ref-type="ref">64</xref> An alternative approach involved in two rRT&#x02010;PCR assays targeting the MERS&#x02010;CoV N gene with a sensitivity of &#x02264;10 copies/reaction, which can complement upE and ORF 1a assays for screening and confirmation has also been published and authorized for emergency use as an in vitro diagnostic test for MERS&#x02010;CoV by the US Food and Drug Administration (FDA).<xref rid="rmv2106-bib-0065" ref-type="ref">
<sup>65</sup>
</xref>
</p><p>Several commercial and in&#x02010;house assays that detect SARS&#x02010;CoV&#x02010;2 RNA have been developed. Chu, et al reported two one&#x02010;step quantitative rRT&#x02010;PCR assays targeting ORF1b and N gene that could detect SARS&#x02010;CoV&#x02010;2&#x02009;&#x0003c;&#x02009;10 copies/reaction, while the N gene assay was about 10 times more sensitive than the ORF1b gene assay in detecting positive clinical specimens.<xref rid="rmv2106-bib-0011" ref-type="ref">
<sup>11</sup>
</xref> It might be possible that clinical samples contain infected cells expressing subgenomic mRNA, resulting in more N gene copies.<xref rid="rmv2106-bib-0066" ref-type="ref">
<sup>66</sup>
</xref> Corman, et al. developed assays targeting E gene and RNA&#x02010;dependent RNA polymerase (RdRp) gene that obtained best sensitivity with limit of detection (LOD) of 5.2 and 3.8 copies/reaction, respectively, while N gene assay was slightly less sensitive.<xref rid="rmv2106-bib-0067" ref-type="ref">
<sup>67</sup>
</xref> Furthermore, when using other basic RT&#x02010;PCR reagents (Taqman Fast Virus 1&#x02010;step Master Mix), another lab obtained the sensitivity of 3.2 copies/reaction for E gene assay and 3.7 copies/reaction for RdRp gene assay.<xref rid="rmv2106-bib-0067" ref-type="ref">
<sup>67</sup>
</xref> Some groups from different countries shared their protocols of in&#x02010;house developed molecular assays. In summary, Chinese CDC recommended primers and probes targeting ORF1ab and N gene.<xref rid="rmv2106-bib-0068" ref-type="ref">
<sup>68</sup>
</xref> In Germany, Charit&#x000e9; recommended E gene assay as first line screening assay with technical LOD of 5.2 copies/reaction, and RdRp gene assay as confirmatory assay with technical LOD of 3.8 copies/reaction.<xref rid="rmv2106-bib-0067" ref-type="ref">
<sup>67</sup>
</xref> Scientists from Hong Kong University recommended the N gene RT&#x02010;PCR as a screening assay and the ORF1b assay as a confirmatory one.<xref rid="rmv2106-bib-0069" ref-type="ref">
<sup>69</sup>
</xref> Ministry of Public Health of Thailand recommended assay targeting N gene.<xref rid="rmv2106-bib-0070" ref-type="ref">
<sup>70</sup>
</xref> National Institute of Infectious Diseases of Japan recommended nested RT&#x02010;PCR assay targeting ORF1a and S gene, as well as RT&#x02010;PCR targeting N gene.<xref rid="rmv2106-bib-0071" ref-type="ref">
<sup>71</sup>
</xref> The US CDC has developed assays including three pairs of primers targeting the N gene of SARS&#x02010;CoV&#x02010;2, and authorized emergency use by the US FDA.<xref rid="rmv2106-bib-0072" ref-type="ref">
<sup>72</sup>
</xref> Details of these assays are summarized in Table <xref rid="rmv2106-tbl-0004" ref-type="table">4</xref>. Most of the in&#x02010;house assays, as well as commercial kits are designed to detect two or three regions of SARS&#x02010;CoV&#x02010;2 genome. The different regions are amplified at the same time. Chinese National Health Commission recommended that both ORF1ab and N should be tested positive for a positive result. If only one region is positive, the result needs to be re&#x02010;tested.<xref rid="rmv2106-bib-0073" ref-type="ref">
<sup>73</sup>
</xref> The US CDC recommended that all the N region targets should be detectable for a positive result, or be undetectable for a negative result. If only one target is positive, the result is inconclusive and need to be re&#x02010;tested.<xref rid="rmv2106-bib-0074" ref-type="ref">
<sup>74</sup>
</xref> So, it is important that all the two or three regions tested should be positive to identify a positive case.</p><table-wrap id="rmv2106-tbl-0004" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 4</label><caption><p>In&#x02010;house assays for detecting SARS&#x02010;CoV&#x02010;2</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Country</th><th align="left" valign="bottom" rowspan="1" colspan="1">Institute</th><th align="left" valign="bottom" rowspan="1" colspan="1">Gene target</th><th align="left" valign="bottom" rowspan="1" colspan="1">Primers and probes</th><th align="left" valign="bottom" rowspan="1" colspan="1">Sensitivity</th></tr></thead><tbody valign="top"><tr><td rowspan="6" align="left" valign="top" colspan="1">China</td><td rowspan="6" align="left" valign="top" colspan="1">China CDC</td><td rowspan="3" align="left" valign="top" colspan="1">ORF1ab</td><td align="left" valign="top" rowspan="1" colspan="1">F: CCCTGTGGGTTTTACACTTAA</td><td rowspan="6" align="left" valign="top" colspan="1">N/A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">R: ACGATTGTGCATCAGCTGA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P:FAM&#x02010;CCGTCTGCGGTATGTGGAAAGGTTATGG&#x02010;BHQ1</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">N</td><td align="left" valign="top" rowspan="1" colspan="1">F:GGGGAACTTCTCCTGCTAGAAT</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">R: CAGACATTTTGCTCTCAAGCTG</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P: FAM&#x02010;TTGCTGCTGCTTGACAGATT&#x02010;TAMRA</td></tr><tr><td rowspan="7" align="left" valign="top" colspan="1">Germany</td><td rowspan="7" align="left" valign="top" colspan="1">Charit&#x000e9;</td><td rowspan="3" align="left" valign="top" colspan="1">E</td><td align="left" valign="top" rowspan="1" colspan="1">F:ACAGGTACGTTAATAGTTAATAGCGT</td><td rowspan="3" align="left" valign="top" colspan="1">5.2 copies/reaction screening assay</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">R:ATATTGCAGCAGTACGCACACA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P:FAM&#x02010;ACACTAGCCATCCTTACTGCGCTTCG&#x02010;BBQ</td></tr><tr><td rowspan="4" align="left" valign="top" colspan="1">RdRp</td><td align="left" valign="top" rowspan="1" colspan="1">F:GTGARATGGTCATGTGTGGCGG</td><td rowspan="4" align="left" valign="top" colspan="1">3.8 copies/reaction confirmatory assay</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">R:CARATGTTAAASACACTATTAGCATA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P2:FAM&#x02010;CAGGTGGAACCTCATCAGGAGATGC&#x02010;BBQ</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P1:FAM&#x02010;CCAGGTGGWACRTCATCMGGTGATGC&#x02010;BBQ</td></tr><tr><td rowspan="6" align="left" valign="top" colspan="1">China</td><td rowspan="6" align="left" valign="top" colspan="1">HKU</td><td rowspan="3" align="left" valign="top" colspan="1">N</td><td align="left" valign="top" rowspan="1" colspan="1">F: TAATCAGACAAGGAACTGATTA</td><td rowspan="3" align="left" valign="top" colspan="1">2<sup>&#x02212;4</sup>&#x02010;2000 TCID50/reaction screening assay</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">R: CGAAGGTGTGACTTCCATG</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P: FAM&#x02010;GCAAATTGTGCAATTTGCGG&#x02010;TAMRA</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">ORF1b</td><td align="left" valign="top" rowspan="1" colspan="1">F: TGGGGYTTTACRGGTAACCT</td><td rowspan="3" align="left" valign="top" colspan="1">2<sup>&#x02212;4</sup>&#x02010;2000 TCID50/reaction confirmatory assay</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">R: AACRCGCTTAACAAAGCACTC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P:FAM&#x02010;TAGTTGTGATGCWATCATGACTAG&#x02010;TAMRA </td></tr><tr><td rowspan="15" align="left" valign="top" colspan="1">Japan</td><td rowspan="15" align="left" valign="top" colspan="1">National Institute of Infectious Diseases</td><td rowspan="6" align="left" valign="top" colspan="1">ORF1a</td><td align="left" valign="top" rowspan="1" colspan="1">1st&#x02010;F:TTCGGATGCTCGAACTGCACC</td><td rowspan="12" align="left" valign="top" colspan="1">Nested RT&#x02010;PCR</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">1st&#x02010;R:CTTTACCAGCACGTGCTAGAAGG</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2nd&#x02010;F:CTCGAACTGCACCTCATGG</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2nd&#x02010;R:CAGAAGTTGTTATCGACATAGC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Seq&#x02010;F:ACCTCATGGTCATGTTATGG</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Seq&#x02010;R:GACATAGCGAGTGTATGCC</td></tr><tr><td rowspan="6" align="left" valign="top" colspan="1">S</td><td align="left" valign="top" rowspan="1" colspan="1">1st&#x02010;F:TTGGCAAAATTCAAGACTCACTTT</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">1st&#x02010;R:TGTGGTTCATAAAAATTCCTTTGTG</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2nd&#x02010;F:CTCAAGACTCACTTTCTTCCAC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2nd&#x02010;R:ATTTGAAACAAAGACACCTTCAC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Seq&#x02010;F:AAGACTCACTTTCTTCCACAG</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Seq&#x02010;R:CAAAGACACCTTCACGAGG</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">N</td><td align="left" valign="top" rowspan="1" colspan="1">F:AAATTTTGGGGACCAGGAAC</td><td rowspan="3" align="left" valign="top" colspan="1">
<p>Five copies/reaction</p>
<p>Real&#x02010;time RT&#x02010;PCR</p>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">R:TGGCAGCTGTGTAGGTCAAC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P:FAM&#x02010;ATGTCGCGCATTGGCATGGA&#x02010;BHQ</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">Thailand</td><td rowspan="3" align="left" valign="top" colspan="1">National Institute of Health</td><td rowspan="3" align="left" valign="top" colspan="1">N</td><td align="left" valign="top" rowspan="1" colspan="1">F:CGTTTGGTGGACCCTCAGAT</td><td rowspan="3" align="left" valign="top" colspan="1">N/A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">R:CCCCACTGCGTTCTCCATT</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P:FAM&#x02010;CAACTGGCAGTAACCA&#x02010;BQH1</td></tr><tr><td rowspan="9" align="left" valign="top" colspan="1">United States</td><td rowspan="9" align="left" valign="top" colspan="1">US CDC</td><td rowspan="3" align="left" valign="top" colspan="1">N1</td><td align="left" valign="top" rowspan="1" colspan="1">F:GACCCCAAAATCAGCGAAAT</td><td rowspan="9" align="left" valign="top" colspan="1">N/A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">R:TCTGGTTACTGCCAGTTGAATCTG</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P:FAM&#x02010;ACCCCGCATTACGTTTGGTGGACC&#x02010;BHQ1</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">N2</td><td align="left" valign="top" rowspan="1" colspan="1">F:TTACAAACATTGGCCGCAAA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">R:GCGCGACATTCCGAAGAA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P:FAM&#x02010;ACAATTTGCCCCCAGCGCTTCAG&#x02010;BHQ1</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">N3</td><td align="left" valign="top" rowspan="1" colspan="1">F:GGGAGCCTTGAATACACCAAAA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">R:TGTAGCACGATTGCAGCATTG</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P:FAM&#x02010;AYCACATTGGCACCCGCAATCCTG&#x02010;BHQ1</td></tr></tbody></table><table-wrap-foot id="rmv2106-ntgp-0004"><fn id="rmv2106-note-0006"><p>Abbreviations: N/A, Not applicable; RT&#x02010;PCR, reverse transcription&#x02010;polymerase chain reaction.</p></fn></table-wrap-foot></table-wrap><p>RT&#x02010;PCR relies on sophisticated equipment that it may not be present in resource&#x02010;limited regions. These limitations gave birth to alternative isothermal amplification methods, such as transcription&#x02010;mediated amplification (TMA), nucleic acid sequence&#x02010;based amplification (NASBA), strand displacement amplification (SDA), loop&#x02010;mediated isothermal amplification (LAMP), helicase&#x02010;dependent amplification (HDA), isothermal recombinase polymerase amplification (RPA), and rolling&#x02010;circle amplification (RCA).<xref rid="rmv2106-bib-0075" ref-type="ref">75</xref>, <xref rid="rmv2106-bib-0076" ref-type="ref">76</xref>, <xref rid="rmv2106-bib-0077" ref-type="ref">77</xref>, <xref rid="rmv2106-bib-0078" ref-type="ref">78</xref>, <xref rid="rmv2106-bib-0079" ref-type="ref">79</xref>, <xref rid="rmv2106-bib-0080" ref-type="ref">80</xref> These alternative isothermal amplification methods are simple, rapid, specific and sensitive which only need a heating block or water bath capable of maintaining a constant temperature.<xref rid="rmv2106-bib-0081" ref-type="ref">81</xref>, <xref rid="rmv2106-bib-0082" ref-type="ref">82</xref> Chantratita, et al developed a real time NASBA assay that could detect as little as one copy/reaction of SARS&#x02010;CoV RNA.<xref rid="rmv2106-bib-0083" ref-type="ref">
<sup>83</sup>
</xref> Compared to RT&#x02010;PCR, a RT&#x02010;LAMP assay of SARS&#x02010;CoV showed 100&#x02010;fold&#x02010;greater sensitivity, with a detection limit of 0.01 PFU.<xref rid="rmv2106-bib-0084" ref-type="ref">
<sup>84</sup>
</xref> In another study, detection rate of the RT&#x02010;LAMP assay was lower than the RT&#x02010;PCR assay for samples isolated from patients within the first 3&#x02009;days of disease onset, and was similar to RT&#x02010;PCR when detecting specimens sampled from patients with more than 3&#x02009;days of illness.<xref rid="rmv2106-bib-0085" ref-type="ref">
<sup>85</sup>
</xref> A RT&#x02010;RCA assay for SARS&#x02010;CoV could detect as few as five copies of SARS viral genome.<xref rid="rmv2106-bib-0086" ref-type="ref">
<sup>86</sup>
</xref> For MERS&#x02010;CoV, a RT&#x02010;RPA method targeting the N gene could detect virus RNA with a sensitivity of 10 copies/reaction. In addition, the run time of the RT&#x02010;RPA was between 3 and 7 minutes for 10<sup>7</sup> and 10 molecules, respectively.<xref rid="rmv2106-bib-0087" ref-type="ref">
<sup>87</sup>
</xref> Several RT&#x02010;LAMP methods have also been developed for MERS&#x02010;CoV detection with a high sensitivity.<xref rid="rmv2106-bib-0088" ref-type="ref">88</xref>, <xref rid="rmv2106-bib-0089" ref-type="ref">89</xref>, <xref rid="rmv2106-bib-0090" ref-type="ref">90</xref>, <xref rid="rmv2106-bib-0091" ref-type="ref">91</xref>, <xref rid="rmv2106-bib-0092" ref-type="ref">92</xref>, <xref rid="rmv2106-bib-0093" ref-type="ref">93</xref> Further alternative isothermal amplification methods for detecting SARS&#x02010;CoV&#x02010;2 genome need to be established, and would show potential applicability for point of care testing (POCT) in resource&#x02010;limited areas.</p><p>In 2002, Jansen et al. firstly discovered clustered regularly interspaced short palindromic repeats (CRISPR) system.<xref rid="rmv2106-bib-0094" ref-type="ref">
<sup>94</sup>
</xref> In 2003, it was confirmed for the first time that CRISPR&#x02010;Cas9 can be used to edit human genes.<xref rid="rmv2106-bib-0095" ref-type="ref">
<sup>95</sup>
</xref> In 2017, combining RPA and CRISPR&#x02010;Cas13a, SHERLOCK system was developed for NAT.<xref rid="rmv2106-bib-0057" ref-type="ref">
<sup>57</sup>
</xref> SHERLOCK detected viral particles down to 2 aM, and could discriminate between similar viral strains.<xref rid="rmv2106-bib-0057" ref-type="ref">
<sup>57</sup>
</xref> Recently, a protocol for detection of SARS&#x02010;CoV&#x02010;2 using SHERLOCK system has been published.<xref rid="rmv2106-bib-0096" ref-type="ref">
<sup>96</sup>
</xref> This method can detect SARS&#x02010;CoV&#x02010;2 in a range between 20 and 200 aM (10&#x02010;100 copies per microliter of input) within an hour. However, this method has not yet been validated with real patient samples, so it should not be used for clinical purposes now.</p><p>Although many RT&#x02010;PCR assays for the SARS&#x02010;CoV&#x02010;2 have been developed, NAT positive cases only account for about 50% of clinically confirmed cases. To raise the positive rate of NAT, standard collection, strict storage and transportation conditions, proper extraction and amplification procedures are needed. To increase test sensitivity, increasing the template volume and total reagent volume for a single run would be very useful. To improve test specificity, amplifying a second genome region for confirmation is suggested. Most importantly, appropriate controls should be established to ensure the results are reliable. For SARS&#x02010;CoV, which are also suitable for other viruses, WHO recommended one negative control and one positive control for extraction, one water control and one positive control for a PCR run, and the patient sample spiked with a weak positive control to detect PCR inhibitory substances (inhibition control).<xref rid="rmv2106-bib-0097" ref-type="ref">
<sup>97</sup>
</xref> Except for these external controls, internal controls, including plasmid DNA, virus&#x02010;like particles (VLPs), RNase P gene, and housekeeping genes of airway epithelial cells such as beta&#x02010;actin have been used for NAT of respiratory viruses including SARS&#x02010;CoV&#x02010;2. Of all these kinds of internal controls, only RNase P presents in all types of SARS&#x02010;CoV&#x02010;2 infected samples and can control the quality of all procedures, from sample collection to amplification (Table <xref rid="rmv2106-tbl-0005" ref-type="table">5</xref>). Thus, we recommend RNase P as internal control when amplifying SARS&#x02010;CoV&#x02010;2 RNA.</p><table-wrap id="rmv2106-tbl-0005" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 5</label><caption><p>Internal control of nucleic acid test</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Internal control type</th><th align="left" valign="bottom" rowspan="1" colspan="1">Nucleic acid type</th><th align="left" valign="bottom" rowspan="1" colspan="1">Preparation</th><th align="left" valign="bottom" rowspan="1" colspan="1">Risk of contaminating sample RNA</th><th align="left" valign="bottom" rowspan="1" colspan="1">Sample collection control</th><th align="left" valign="bottom" rowspan="1" colspan="1">Extraction control</th><th align="left" valign="bottom" rowspan="1" colspan="1">Reverse transcription control</th><th align="left" valign="bottom" rowspan="1" colspan="1">Amplification control</th><th align="left" valign="bottom" rowspan="1" colspan="1">Inhibition control</th><th align="left" valign="bottom" rowspan="1" colspan="1">Competent or non&#x02010;competent control</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">RNase P</td><td align="left" valign="top" rowspan="1" colspan="1">RNA</td><td align="left" valign="top" rowspan="1" colspan="1">Easy</td><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">Housekeeping gene of airway epithelial cells</td><td align="left" valign="top" rowspan="1" colspan="1">mRNA</td><td align="left" valign="top" rowspan="1" colspan="1">Easy</td><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td colspan="6" align="left" valign="top" rowspan="1">Only applicable to respiratory specimens</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Plasmid DNA</td><td align="left" valign="top" rowspan="1" colspan="1">DNA</td><td align="left" valign="top" rowspan="1" colspan="1">Complex</td><td align="left" valign="top" rowspan="1" colspan="1">High</td><td align="left" valign="top" rowspan="1" colspan="1">&#x000d7;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x000d7;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x000d7;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Virus&#x02010;like particles</td><td align="left" valign="top" rowspan="1" colspan="1">RNA</td><td align="left" valign="top" rowspan="1" colspan="1">More complex</td><td align="left" valign="top" rowspan="1" colspan="1">High</td><td align="left" valign="top" rowspan="1" colspan="1">&#x000d7;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0221a;</td></tr></tbody></table></table-wrap></sec><sec id="rmv2106-sec-0005"><label>2.3</label><title>Serological tests</title><p>Serological testing may be conducted for diagnosis in rare situations where NAT is not possible, for investigation of an ongoing outbreak, or for serological surveys, including to retrospectively assess the extent of an outbreak.<xref rid="rmv2106-bib-0062" ref-type="ref">
<sup>62</sup>
</xref> Although antibody seroconversion provides reliable proof of infection, serological testing lags behind the detection of viral genome by molecular testing, making it not suitable for early diagnosis. In SARS, higher neutralizing antibody response was associated with a longer illness.<xref rid="rmv2106-bib-0013" ref-type="ref">
<sup>13</sup>
</xref> In most MERS patients, the levels of IgG and neutralizing antibodies were weekly and inversely correlated with LRT viral loads.<xref rid="rmv2106-bib-0051" ref-type="ref">
<sup>51</sup>
</xref> In addition, an early MERS&#x02010;CoV antibody response was associated with reduced disease severity.<xref rid="rmv2106-bib-0098" ref-type="ref">
<sup>98</sup>
</xref> Thus, testing antibody is helpful for surveillance, prediction of disease outcome and epidemiological investigation, but not for early diagnosis.</p><p>A variety of serological assays were established for detecting SARS&#x02010;CoV and MERS&#x02010;CoV, mainly including enzyme&#x02010;linked immunosorbent assay (ELISA), chemiluminescence assay (CLIA), immunofluorescence assay (IFA), western blot (WB), protein microarray, and neutralization. Of these methods, ELISA and CLIA are suitable for first line screening because of the large throughput, short processing time, and simple operating procedure, while neutralization assay is used as the gold standard for confirmation in many laboratories.</p><p>The basic issue in serological assays is the source of antigen. Once virus has been isolated from patients, cell lysate or supernatant of virus infected cells could be used for serological assays. These methods are most convenient and rapid, as they only need susceptible cell cultures and virus. However, they need to be performed in BSL&#x02010;3, and proper inactivation of the virus without reducing immunogenicity of antigens is required, thus limiting the widespread use of virus&#x02010;based serological testing. Furthermore, cross reaction is likely to happen because of the conserved sequence and structure between CoVs. By cloning immunogenic viral genes into prokaryotic or eukaryotic expression plasmids, transfecting the plasmids into bacterial or mammalian cells and purifying proteins, recombinant antigens can be developed to overcome the disadvantages of virus infected cells.<xref rid="rmv2106-bib-0099" ref-type="ref">
<sup>99</sup>
</xref> Recombinant antigens are safe and do not require BSL&#x02010;3 containment. Importantly, although taking longer time and more steps for development, recombinant antigen based assays enable the selection of immunogenic and virus specific antigens to maximize both specificity and sensitivity, and more suitable for standardization.<xref rid="rmv2106-bib-0100" ref-type="ref">
<sup>100</sup>
</xref> In SARS&#x02010;CoV and MERS&#x02010;CoV, N and S protein are the major immunogenic proteins and the first choice for producing recombinant antigens. Antibodies to proteins S, 3a, N, and 9b were detected in the sera from convalescent&#x02010;phase SARS patients. Among them, anti&#x02010;S and anti&#x02010;N were dominant and could persist in the sera of SARS patients until week 30, while only anti&#x02010;S3 showed significant neutralizing activity.<xref rid="rmv2106-bib-0101" ref-type="ref">
<sup>101</sup>
</xref> Anti&#x02010;N appeared earlier than anti&#x02010;S, indicating that S protein&#x02010;based assays may be preferable for use with convalescent sera.<xref rid="rmv2106-bib-0102" ref-type="ref">102</xref>, <xref rid="rmv2106-bib-0103" ref-type="ref">103</xref> Sera tend to react against both antigens with higher sensitivity.<xref rid="rmv2106-bib-0102" ref-type="ref">
<sup>102</sup>
</xref> Cross reaction also happened in assays using recombinant antigens. Moderate cross&#x02010;reactivity between SARS&#x02010;CoV and porcine CoVs was mediated through amino acids 120 to 208 of the N protein.<xref rid="rmv2106-bib-0104" ref-type="ref">
<sup>104</sup>
</xref> Bioinformatics analysis demonstrated a significant B&#x02010;cell epitope overlapping the heptad repeat&#x02010;2 region of S protein of SARS&#x02010;CoV and HCoV&#x02010;EMC,<xref rid="rmv2106-bib-0105" ref-type="ref">
<sup>105</sup>
</xref> which is known to harbor an epitope for broadly neutralizing antibody in the case of SARS&#x02010;CoV.<xref rid="rmv2106-bib-0106" ref-type="ref">
<sup>106</sup>
</xref> As a result, convalescent SARS sera cross reacted with HCoV&#x02010;EMC.<xref rid="rmv2106-bib-0105" ref-type="ref">
<sup>105</sup>
</xref> Thus, for SARS&#x02010;CoV&#x02010;2, specific recombinant antigens are required. Also, testing antibodies with different assays targeting different regions of antigens could avoid false&#x02010;positive results produced by cross reaction.</p><p>WHO declared that positive antibody test results indicated a previous infection with SARS&#x02010;CoV. Seroconversion from negative to positive or a 4&#x02010;fold rise in antibody titer from acute to convalescent serum indicated recent infection. No detection of antibody after 21&#x02009;days from onset of illness seemed to indicate that no infection with SARS&#x02010;CoV took place.<xref rid="rmv2106-bib-0107" ref-type="ref">
<sup>107</sup>
</xref> For MERS&#x02010;CoV, the US CDC recommended ELISA as a screening test and microneutralization as a confirmatory test for MERS&#x02010;CoV antibodies.<xref rid="rmv2106-bib-0108" ref-type="ref">
<sup>108</sup>
</xref> Where a patient has evidence of seroconversion in at least one screening assay and confirmation by a neutralization assay in samples ideally taken at least 14&#x02009;days apart, this patient can be considered a confirmed case. A 4&#x02010;fold increase in MERS&#x02010;CoV antibody titer by neutralization tests in acute and convalescent serum samples performed in parallel is needed for confirmation.<xref rid="rmv2106-bib-0062" ref-type="ref">
<sup>62</sup>
</xref> For conducting serology of SARS&#x02010;CoV&#x02010;2, or broad CoV serology on paired samples (in the acute and convalescent phase), WHO recommended that the first serum sample should be collected in week 1 of illness and the second collected 3 to 4&#x02009;weeks later, collecting at least 3&#x02009;weeks after onset of symptoms if only a single serum sample can be collected.<xref rid="rmv2106-bib-0034" ref-type="ref">
<sup>34</sup>
</xref>
</p><p>In SARS, IgG seroconversion was documented in 93% patients at mean of 20&#x02009;days.<xref rid="rmv2106-bib-0043" ref-type="ref">
<sup>43</sup>
</xref> Positive antibody, neutralizing antibody titer of most patients was shown to peak between Weeks 5 and 8 after onset and to decline with a half&#x02010;life of 6.4&#x02009;weeks.<xref rid="rmv2106-bib-0013" ref-type="ref">
<sup>13</sup>
</xref> In most MERS patients, robust antibody responses developed by the third week of illness, and were delayed further in severely ill patients requiring mechanical ventilation.<xref rid="rmv2106-bib-0051" ref-type="ref">51</xref>, <xref rid="rmv2106-bib-0098" ref-type="ref">98</xref> An IgG and IgM ELISA test which used bat SARS&#x02010;related&#x02010;CoV (SARSr&#x02010;CoV) Rp3 nucleocapsid protein (NP) as antigen was developed previously.<xref rid="rmv2106-bib-0109" ref-type="ref">
<sup>109</sup>
</xref> This SARSr&#x02010;CoV NP is 92% identical to SARS&#x02010;CoV&#x02010;2 NP, thus this assay was used for serological testing of SARS&#x02010;CoV&#x02010;2.<xref rid="rmv2106-bib-0023" ref-type="ref">
<sup>23</sup>
</xref> Both IgM and IgG titres were relatively low or undetectable in first sampling (not first day of illness). On Day 5, an increase of viral antibodies can be seen in nearly all patients. IgM positive rate increased from 50% to 81%, whereas IgG positive rate increase from 81% to 100%.<xref rid="rmv2106-bib-0023" ref-type="ref">
<sup>23</sup>
</xref> This is in contrast to a relatively low detection positive rate from molecular test. Based on this result, serological testing might improve the detection positive rate. However, the clinical records of patients involved in this study were not available. Although the target patients were those who received around 10&#x02009;days of medical treatments upon admission, it is not sure on which days of illness the high positive rate of IgG and IgM occurred. Diverse assays and more evidence are needed to confirm the IgG and IgM kinetics of SARS&#x02010;CoV&#x02010;2.</p></sec></sec><sec id="rmv2106-sec-0006"><label>3</label><title>CONCLUSION</title><p>With the progress of global integration, emerging and reemerging infectious diseases are becoming easier to transmit all over the world. The very important and first key to respond to outbreaks is early discovery. Laboratory testing plays the major role in early detection of infected persons, enabling recognition of the infection source and cutting off the transmission route. The results of laboratory testing are affected by various factors. To improve NAT capacity of SARS&#x02010;CoV&#x02010;2 RNA, we summarized the literature and guidelines and suggested that: (a) If LRT specimens are unavailable, collect stool and blood samples at later period of illness to improve the positive rate of NAT. (b) Increase template volume to raise the sensitivity of detection. (c) Put samples in reagents containing guanidine salt such as TRIZOL, TRIZOL LS, or AVL buffer to inactivate virus as well as protect RNA. (d) Set proper positive, negative and inhibition controls for extraction and amplification to ensure quality results. (e) Simultaneously amplify human RNase P gene as internal control to avoid false&#x02010;negative results. At the time of writing this review, serological evidence of SARS&#x02010;CoV&#x02010;2 is still poor. Diverse assays targeting different antigens are needed. Also, collecting paired samples would help to monitor the kinetics and positive rates of serological testing in different periods of diseases.</p></sec><sec sec-type="COI-statement" id="rmv2106-sec-0007"><title>CONFLICT OF INTEREST</title><p>All authors have no conflict interest to disclose.</p></sec></body><back><ref-list id="rmv2106-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="rmv2106-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="rmv2106-cit-0001">
<string-name>
<surname>Song</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Bao</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>From SARS to MERS, thrusting coronaviruses into the spotlight</article-title>. <source xml:lang="en">Viruses</source>. <year>2019</year>;<volume>11</volume>(<issue>1</issue>):59.</mixed-citation></ref><ref id="rmv2106-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="rmv2106-cit-0002">
<string-name>
<surname>Zhu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>A novel coronavirus from patients with pneumonia in China, 2019</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2020</year>;<volume>382</volume>(<issue>8</issue>):<fpage>727</fpage>&#x02010;<lpage>733</lpage>.<pub-id pub-id-type="pmid">31978945</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="rmv2106-cit-0003">
<string-name>
<surname>Gorbalenya</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Baric</surname>
<given-names>RS</given-names>
</string-name>, et al. <article-title>Severe acute respiratory syndrome&#x02010;related coronavirus: The species and its viruses &#x02013; a statement of the Coronavirus Study Group</article-title>. <source xml:lang="en">bioRxiv</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.02.07.937862</pub-id>
</mixed-citation></ref><ref id="rmv2106-bib-0004"><label>4</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0004">
<collab collab-type="authors">WHO</collab>
. Coronavirus disease (COVID&#x02010;2019) situation reports. <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="rmv2106-cit-0005">
<string-name>
<surname>Weiss</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Leibowitz</surname>
<given-names>JL</given-names>
</string-name>. <article-title>Coronavirus pathogenesis</article-title>. <source xml:lang="en">Adv Virus Res</source>. <year>2011</year>;<volume>81</volume>:<fpage>85</fpage>&#x02010;<lpage>164</lpage>.<pub-id pub-id-type="pmid">22094080</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="rmv2106-cit-0006">
<string-name>
<surname>Cui</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>ZL</given-names>
</string-name>. <article-title>Origin and evolution of pathogenic coronaviruses</article-title>. <source xml:lang="en">Nat Rev Microbiol</source>. <year>2019</year>;<volume>17</volume>(<issue>3</issue>):<fpage>181</fpage>&#x02010;<lpage>192</lpage>.<pub-id pub-id-type="pmid">30531947</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="rmv2106-cit-0007">
<string-name>
<surname>Yin</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wunderink</surname>
<given-names>RG</given-names>
</string-name>. <article-title>MERS, SARS and other coronaviruses as causes of pneumonia</article-title>. <source xml:lang="en">Respirology</source>. <year>2018</year>;<volume>23</volume>(<issue>2</issue>):<fpage>130</fpage>&#x02010;<lpage>137</lpage>.<pub-id pub-id-type="pmid">29052924</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="rmv2106-cit-0008">
<string-name>
<surname>Su</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>Epidemiology, genetic recombination, and pathogenesis of coronaviruses</article-title>. <source xml:lang="en">Trends Microbiol</source>. <year>2016</year>;<volume>24</volume>(<issue>6</issue>):<fpage>490</fpage>&#x02010;<lpage>502</lpage>.<pub-id pub-id-type="pmid">27012512</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="rmv2106-cit-0009">
<string-name>
<surname>Shi</surname>
<given-names>ZL</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Rottier</surname>
<given-names>PJ</given-names>
</string-name>. <article-title>Coronavirus: epidemiology, genome replication and the interactions with their hosts</article-title>. <source xml:lang="en">Virol Sin</source>. <year>2016</year>;<volume>31</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02010;<lpage>2</lpage>.<pub-id pub-id-type="pmid">26908210</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="rmv2106-cit-0010">
<string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Horby</surname>
<given-names>PW</given-names>
</string-name>, <string-name>
<surname>Hayden</surname>
<given-names>FG</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>GF</given-names>
</string-name>. <article-title>A novel coronavirus outbreak of global health concern</article-title>. <source xml:lang="en">Lancet</source>. <year>2020</year>;<volume>395</volume>(<issue>10223</issue>):<fpage>470</fpage>&#x02010;<lpage>473</lpage>.<pub-id pub-id-type="pmid">31986257</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="rmv2106-cit-0011">
<string-name>
<surname>Chu</surname>
<given-names>DKW</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>SMS</given-names>
</string-name>, et al. <article-title>Molecular diagnosis of a novel coronavirus (2019&#x02010;nCoV) causing an outbreak of pneumonia</article-title>. <source xml:lang="en">Clin Chem</source>. <year>2020</year>;<volume>66</volume>(<issue>4</issue>):549&#x02010;555.</mixed-citation></ref><ref id="rmv2106-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="rmv2106-cit-0012">
<string-name>
<surname>Wang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus&#x02010;infected pneumonia in Wuhan, China</article-title>. <source xml:lang="en">JAMA</source>. <year>2020</year>;<volume>323</volume>(<issue>11</issue>):1061&#x02010;1069.</mixed-citation></ref><ref id="rmv2106-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="rmv2106-cit-0013">
<string-name>
<surname>Gu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gong</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Multiple organ infection and the pathogenesis of SARS</article-title>. <source xml:lang="en">J Exp Med</source>. <year>2005</year>;<volume>202</volume>(<issue>3</issue>):<fpage>415</fpage>&#x02010;<lpage>424</lpage>.<pub-id pub-id-type="pmid">16043521</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="rmv2106-cit-0014">
<string-name>
<surname>Shi</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Gong</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases</article-title>. <source xml:lang="en">Am J Gastroenterol</source>. <year>2005</year>;<volume>100</volume>(<issue>1</issue>):<fpage>169</fpage>&#x02010;<lpage>176</lpage>.<pub-id pub-id-type="pmid">15654797</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="rmv2106-cit-0015">
<string-name>
<surname>Alsaad</surname>
<given-names>KO</given-names>
</string-name>, <string-name>
<surname>Hajeer</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Al Balwi</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Histopathology of Middle East respiratory syndrome coronovirus (MERS&#x02010;CoV) infection &#x02013; clinicopathological and ultrastructural study</article-title>. <source xml:lang="en">Histopathology</source>. <year>2018</year>;<volume>72</volume>(<issue>3</issue>):<fpage>516</fpage>&#x02010;<lpage>524</lpage>.<pub-id pub-id-type="pmid">28858401</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="rmv2106-cit-0016">
<string-name>
<surname>Zaki</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>van Boheemen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bestebroer</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Osterhaus</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Fouchier</surname>
<given-names>RA</given-names>
</string-name>. <article-title>Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2012</year>;<volume>367</volume>(<issue>19</issue>):<fpage>1814</fpage>&#x02010;<lpage>1820</lpage>.<pub-id pub-id-type="pmid">23075143</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="rmv2106-cit-0017">
<string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Moore</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Vasilieva</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Angiotensin&#x02010;converting enzyme 2 is a functional receptor for the SARS coronavirus</article-title>. <source xml:lang="en">Nature</source>. <year>2003</year>;<volume>426</volume>(<issue>6965</issue>):<fpage>450</fpage>&#x02010;<lpage>454</lpage>.<pub-id pub-id-type="pmid">14647384</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="rmv2106-cit-0018">
<string-name>
<surname>Wrapp</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Corbett</surname>
<given-names>KS</given-names>
</string-name>, et al. <article-title>Cryo&#x02010;EM structure of the 2019&#x02010;nCoV spike in the prefusion conformation</article-title>. <source xml:lang="en">Science</source>. <year>2020</year>;<volume>367</volume>:<fpage>1260</fpage>&#x02010;<lpage>1263</lpage>.<pub-id pub-id-type="pmid">32075877</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="rmv2106-cit-0019">
<string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Clinical course and outcomes of critically ill patients with SARS&#x02010;CoV&#x02010;2 pneumonia in Wuhan, China: a single&#x02010;centered, retrospective, observational study</article-title>. <source xml:lang="en">Lancet Respir Med</source>. <year>2020</year>; pii/S2213&#x02010;2600(20)30079&#x02010;5. </mixed-citation></ref><ref id="rmv2106-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="rmv2106-cit-0020">
<string-name>
<surname>Griffith</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Antonio</surname>
<given-names>GE</given-names>
</string-name>, <string-name>
<surname>Kumta</surname>
<given-names>SM</given-names>
</string-name>, et al. <article-title>Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids</article-title>. <source xml:lang="en">Radiology</source>. <year>2005</year>;<volume>235</volume>(<issue>1</issue>):<fpage>168</fpage>&#x02010;<lpage>175</lpage>.<pub-id pub-id-type="pmid">15703312</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="rmv2106-cit-0021">
<string-name>
<surname>Chan</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Griffith</surname>
<given-names>JF</given-names>
</string-name>, et al. <article-title>Steroid&#x02010;induced osteonecrosis in severe acute respiratory syndrome: a retrospective analysis of biochemical markers of bone metabolism and corticosteroid therapy</article-title>. <source xml:lang="en">Pathology</source>. <year>2006</year>;<volume>38</volume>(<issue>3</issue>):<fpage>229</fpage>&#x02010;<lpage>235</lpage>.<pub-id pub-id-type="pmid">16753744</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0022"><label>22</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0022">
<collab collab-type="authors">Chinese National Health Commission</collab>
. Guideline for diagnosis and treatment of COVID&#x02010;19. <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="rmv2106-cit-0023">
<string-name>
<surname>Zhang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Molecular and serological investigation of 2019&#x02010;nCoV infected patients: implication of multiple shedding routes</article-title>. <source xml:lang="en">Emerg Microbes Infect</source>. <year>2020</year>;<volume>9</volume>(<issue>1</issue>):<fpage>386</fpage>&#x02010;<lpage>389</lpage>.<pub-id pub-id-type="pmid">32065057</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="rmv2106-cit-0024">
<string-name>
<surname>Ling</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>YX</given-names>
</string-name>, et al. <article-title>Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients</article-title>. <source xml:lang="en">Chin Med J (Engl)</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1097/CM9.0000000000000774</pub-id>
</mixed-citation></ref><ref id="rmv2106-bib-0025"><label>25</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0025">
<collab collab-type="authors">WHO</collab>
. Clinical management of severe acute respiratory infection when novel coronavirus (2019&#x02010;nCoV) infection is suspected. <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0026"><label>26</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0026">
<collab collab-type="authors">US CDC</collab>
. Interim Guidance for Discontinuation of Transmission&#x02010;Based Precautions and Disposition of Hospitalized Patients with COVID&#x02010;19. <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0027"><label>27</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0027">
<collab collab-type="authors">US CDC</collab>
. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons Under Investigation (PUIs) for Coronavirus Disease 2019 (COVID&#x02010;19). <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0028"><label>28</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0028">
<collab collab-type="authors">US CDC</collab>
. Specimen collection guidelines.</mixed-citation></ref><ref id="rmv2106-bib-0029"><label>29</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0029">
<collab collab-type="authors">Chinese National Health Commission</collab>
. Guideline for laboratory testing of COVID&#x02010;19.</mixed-citation></ref><ref id="rmv2106-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="rmv2106-cit-0030">
<string-name>
<surname>Kim</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ahmed</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Eidex</surname>
<given-names>RB</given-names>
</string-name>, et al. <article-title>Comparison of nasopharyngeal and oropharyngeal swabs for the diagnosis of eight respiratory viruses by real&#x02010;time reverse transcription&#x02010;PCR assays</article-title>. <source xml:lang="en">PLoS One</source>. <year>2011</year>;<volume>6</volume>(<issue>6</issue>):<elocation-id>e21610</elocation-id>.<pub-id pub-id-type="pmid">21738731</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="rmv2106-cit-0031">
<string-name>
<surname>Ek</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bottiger</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Dahlman</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hansen</surname>
<given-names>KB</given-names>
</string-name>, <string-name>
<surname>Nyman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nilsson</surname>
<given-names>AC</given-names>
</string-name>. <article-title>A combination of naso&#x02010; and oropharyngeal swabs improves the diagnostic yield of respiratory viruses in adult emergency department patients</article-title>. <source xml:lang="en">Infect Dis (Lond)</source>. <year>2019</year>;<volume>51</volume>(<issue>4</issue>):<fpage>241</fpage>&#x02010;<lpage>248</lpage>.<pub-id pub-id-type="pmid">30760088</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="rmv2106-cit-0032">
<string-name>
<surname>Spencer</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Flannery</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Fry</surname>
<given-names>A</given-names>
</string-name>. <article-title>Comparison of respiratory specimen collection methods for detection of influenza virus infection by reverse transcription&#x02010;PCR: a literature review</article-title>. <source xml:lang="en">J Clin Microbiol</source>. <year>2019</year>;<volume>57</volume>(<issue>9</issue>):e00027&#x02010;19.</mixed-citation></ref><ref id="rmv2106-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="rmv2106-cit-0033">
<collab collab-type="authors">To KK</collab>
, <string-name>
<surname>Tsang</surname>
<given-names>OT</given-names>
</string-name>, <string-name>
<surname>Chik&#x02010;Yan Yip</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Consistent detection of 2019 novel coronavirus in saliva</article-title>. <source xml:lang="en">Clin Infect Dis</source>. <year>2020</year>;pii/ciaa149. <pub-id pub-id-type="doi">10.1093/cid/ciaa149</pub-id>
</mixed-citation></ref><ref id="rmv2106-bib-0034"><label>34</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0034">
<collab collab-type="authors">WHO</collab>
. Laboratory testing for 2019 novel coronavirus (2019&#x02010;nCoV) in suspected human cases. <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0035"><label>35</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0035">
<collab collab-type="authors">WHO</collab>
. Laboratory biosafety guidance related to the novel cornoavirus (2019&#x02010;nCoV). <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="rmv2106-cit-0036">
<string-name>
<surname>Blow</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Mores</surname>
<given-names>CN</given-names>
</string-name>, <string-name>
<surname>Dyer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dohm</surname>
<given-names>DJ</given-names>
</string-name>. <article-title>Viral nucleic acid stabilization by RNA extraction reagent</article-title>. <source xml:lang="en">J Virol Methods</source>. <year>2008</year>;<volume>150</volume>(<issue>1&#x02013;2</issue>):<fpage>41</fpage>&#x02010;<lpage>44</lpage>.<pub-id pub-id-type="pmid">18387678</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="rmv2106-cit-0037">
<string-name>
<surname>Blow</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Dohm</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Negley</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Mores</surname>
<given-names>CN</given-names>
</string-name>. <article-title>Virus inactivation by nucleic acid extraction reagents</article-title>. <source xml:lang="en">J Virol Methods</source>. <year>2004</year>;<volume>119</volume>(<issue>2</issue>):<fpage>195</fpage>&#x02010;<lpage>198</lpage>.<pub-id pub-id-type="pmid">15158603</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="rmv2106-cit-0038">
<string-name>
<surname>Alfson</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Griffiths</surname>
<given-names>A</given-names>
</string-name>. <article-title>Development and testing of a method for validating chemical inactivation of Ebola virus</article-title>. <source xml:lang="en">Viruses</source>. <year>2018</year>;<volume>10</volume>(<issue>3</issue>):126.</mixed-citation></ref><ref id="rmv2106-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="rmv2106-cit-0039">
<string-name>
<surname>Burton</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Easterbrook</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Pitman</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>The effect of a non&#x02010;denaturing detergent and a guanidinium&#x02010;based inactivation agent on the viability of Ebola virus in mock clinical serum samples</article-title>. <source xml:lang="en">J Virol Methods</source>. <year>2017</year>;<volume>250</volume>:<fpage>34</fpage>&#x02010;<lpage>40</lpage>.<pub-id pub-id-type="pmid">28941617</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="rmv2106-cit-0040">
<string-name>
<surname>Kumar</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mazur</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ork</surname>
<given-names>BL</given-names>
</string-name>, et al. <article-title>Inactivation and safety testing of Middle East respiratory syndrome coronavirus</article-title>. <source xml:lang="en">J Virol Methods</source>. <year>2015</year>;<volume>223</volume>:<fpage>13</fpage>&#x02010;<lpage>18</lpage>.<pub-id pub-id-type="pmid">26190637</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="rmv2106-cit-0041">
<string-name>
<surname>Chang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>. <article-title>Coronavirus disease 2019: coronaviruses and blood safety</article-title>. <source xml:lang="en">Transfus Med Rev</source>. <year>2020</year>;pii/S0887&#x02010;7963(20)30014&#x02010;6. <pub-id pub-id-type="doi">10.1016/j.tmrv.2020.02.003</pub-id>
</mixed-citation></ref><ref id="rmv2106-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="rmv2106-cit-0042">
<string-name>
<surname>Hu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>An</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Situ</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS&#x02010;CoV&#x02010;2</article-title>. <source xml:lang="en">medRxiv</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.03.12.20034231</pub-id>
</mixed-citation></ref><ref id="rmv2106-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="rmv2106-cit-0043">
<string-name>
<surname>Peiris</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>VC</given-names>
</string-name>, et al. <article-title>Clinical progression and viral load in a community outbreak of coronavirus&#x02010;associated SARS pneumonia: a prospective study</article-title>. <source xml:lang="en">Lancet</source>. <year>2003</year>;<volume>361</volume>(<issue>9371</issue>):<fpage>1767</fpage>&#x02010;<lpage>1772</lpage>.<pub-id pub-id-type="pmid">12781535</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="rmv2106-cit-0044">
<string-name>
<surname>Cheng</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Tong</surname>
<given-names>LK</given-names>
</string-name>, et al. <article-title>Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome</article-title>. <source xml:lang="en">Lancet</source>. <year>2004</year>;<volume>363</volume>(<issue>9422</issue>):<fpage>1699</fpage>&#x02010;<lpage>1700</lpage>.<pub-id pub-id-type="pmid">15158632</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="rmv2106-cit-0045">
<string-name>
<surname>Oh</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>WB</given-names>
</string-name>, <string-name>
<surname>Choe</surname>
<given-names>PG</given-names>
</string-name>, et al. <article-title>Viral load kinetics of MERS coronavirus infection</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2016</year>;<volume>375</volume>(<issue>13</issue>):<fpage>1303</fpage>&#x02010;<lpage>1305</lpage>.</mixed-citation></ref><ref id="rmv2106-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="rmv2106-cit-0046">
<string-name>
<surname>Kim</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Ko</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Viral load kinetics of SARS&#x02010;CoV&#x02010;2 infection in first two patients in Korea</article-title>. <source xml:lang="en">J Korean Med Sci</source>. <year>2020</year>;<volume>35</volume>(<issue>7</issue>):<elocation-id>e86</elocation-id>.<pub-id pub-id-type="pmid">32080991</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="rmv2106-cit-0047">
<string-name>
<surname>Chan</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>To</surname>
<given-names>WK</given-names>
</string-name>, <string-name>
<surname>Ng</surname>
<given-names>KC</given-names>
</string-name>, et al. <article-title>Laboratory diagnosis of SARS</article-title>. <source xml:lang="en">Emerg Infect Dis</source>. <year>2004</year>;<volume>10</volume>(<issue>5</issue>):<fpage>825</fpage>&#x02010;<lpage>831</lpage>.<pub-id pub-id-type="pmid">15200815</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="rmv2106-cit-0048">
<string-name>
<surname>Chan</surname>
<given-names>KH</given-names>
</string-name>, <string-name>
<surname>Poon</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>VC</given-names>
</string-name>, et al. <article-title>Detection of SARS coronavirus in patients with suspected SARS</article-title>. <source xml:lang="en">Emerg Infect Dis</source>. <year>2004</year>;<volume>10</volume>(<issue>2</issue>):<fpage>294</fpage>&#x02010;<lpage>299</lpage>.<pub-id pub-id-type="pmid">15030700</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="rmv2106-cit-0049">
<string-name>
<surname>Hung</surname>
<given-names>IF</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>VC</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>AK</given-names>
</string-name>, et al. <article-title>Viral loads in clinical specimens and SARS manifestations</article-title>. <source xml:lang="en">Emerg Infect Dis</source>. <year>2004</year>;<volume>10</volume>(<issue>9</issue>):<fpage>1550</fpage>&#x02010;<lpage>1557</lpage>.<pub-id pub-id-type="pmid">15498155</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="rmv2106-cit-0050">
<string-name>
<surname>Drosten</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Seilmaier</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Corman</surname>
<given-names>VM</given-names>
</string-name>, et al. <article-title>Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection</article-title>. <source xml:lang="en">Lancet Infect Dis</source>. <year>2013</year>;<volume>13</volume>(<issue>9</issue>):<fpage>745</fpage>&#x02010;<lpage>751</lpage>.<pub-id pub-id-type="pmid">23782859</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="rmv2106-cit-0051">
<string-name>
<surname>Corman</surname>
<given-names>VM</given-names>
</string-name>, <string-name>
<surname>Albarrak</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Omrani</surname>
<given-names>AS</given-names>
</string-name>, et al. <article-title>Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection</article-title>. <source xml:lang="en">Clin Infect Dis</source>. <year>2016</year>;<volume>62</volume>(<issue>4</issue>):<fpage>477</fpage>&#x02010;<lpage>483</lpage>.<pub-id pub-id-type="pmid">26565003</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="rmv2106-cit-0052">
<string-name>
<surname>Pan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Poon</surname>
<given-names>LLM</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>. <article-title>Viral load of SARS&#x02010;CoV&#x02010;2 in clinical samples</article-title>. <source xml:lang="en">Lancet Infect Dis</source>. <year>2020</year>;<volume>20</volume>(4):411&#x02010;412.</mixed-citation></ref><ref id="rmv2106-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="rmv2106-cit-0053">
<string-name>
<surname>Ng</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Hui</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>KC</given-names>
</string-name>, et al. <article-title>Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome</article-title>. <source xml:lang="en">Clin Chem</source>. <year>2003</year>;<volume>49</volume>(<issue>12</issue>):<fpage>1976</fpage>&#x02010;<lpage>1980</lpage>.<pub-id pub-id-type="pmid">14633867</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="rmv2106-cit-0054">
<string-name>
<surname>Kim</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Cho</surname>
<given-names>SY</given-names>
</string-name>, et al. <article-title>Viral RNA in blood as Indicator of severe outcome in Middle East respiratory syndrome coronavirus infection</article-title>. <source xml:lang="en">Emerg Infect Dis</source>. <year>2016</year>;<volume>22</volume>(<issue>10</issue>):<fpage>1813</fpage>&#x02010;<lpage>1816</lpage>.<pub-id pub-id-type="pmid">27479636</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="rmv2106-cit-0055">
<string-name>
<surname>Chen</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Lan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Detectable 2019&#x02010;nCoV viral RNA in blood is a strong indicator for the further clinical severity</article-title>. <source xml:lang="en">Emerg Microbes Infect</source>. <year>2020</year>;<volume>9</volume>(<issue>1</issue>):<fpage>469</fpage>&#x02010;<lpage>473</lpage>.<pub-id pub-id-type="pmid">32102625</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="rmv2106-cit-0056">
<string-name>
<surname>Grant</surname>
<given-names>PR</given-names>
</string-name>, <string-name>
<surname>Garson</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Tedder</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Tam</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Sung</surname>
<given-names>JJ</given-names>
</string-name>. <article-title>Detection of SARS coronavirus in plasma by real&#x02010;time RT&#x02010;PCR</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2003</year>;<volume>349</volume>(<issue>25</issue>):<fpage>2468</fpage>&#x02010;<lpage>2469</lpage>.<pub-id pub-id-type="pmid">14681520</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="rmv2106-cit-0057">
<string-name>
<surname>Gootenberg</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Abudayyeh</surname>
<given-names>OO</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>JW</given-names>
</string-name>, et al. <article-title>Nucleic acid detection with CRISPR&#x02010;Cas13a/C2c2</article-title>. <source xml:lang="en">Science</source>. <year>2017</year>;<volume>356</volume>(<issue>6336</issue>):<fpage>438</fpage>&#x02010;<lpage>442</lpage>.<pub-id pub-id-type="pmid">28408723</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="rmv2106-cit-0058">
<string-name>
<surname>Nitsche</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Schweiger</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ellerbrok</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Niedrig</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pauli</surname>
<given-names>G</given-names>
</string-name>. <article-title>SARS coronavirus detection</article-title>. <source xml:lang="en">Emerg Infect Dis</source>. <year>2004</year>;<volume>10</volume>(<issue>7</issue>):<fpage>1300</fpage>&#x02010;<lpage>1303</lpage>.<pub-id pub-id-type="pmid">15324554</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="rmv2106-cit-0059">
<string-name>
<surname>Emery</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Erdman</surname>
<given-names>DD</given-names>
</string-name>, <string-name>
<surname>Bowen</surname>
<given-names>MD</given-names>
</string-name>, et al. <article-title>Real&#x02010;time reverse transcription&#x02010;polymerase chain reaction assay for SARS&#x02010;associated coronavirus</article-title>. <source xml:lang="en">Emerg Infect Dis</source>. <year>2004</year>;<volume>10</volume>(<issue>2</issue>):<fpage>311</fpage>&#x02010;<lpage>316</lpage>.<pub-id pub-id-type="pmid">15030703</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="rmv2106-cit-0060">
<string-name>
<surname>Huang</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>HT</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>YM</given-names>
</string-name>, et al. <article-title>Rapid and sensitive detection of multiple genes from the SARS&#x02010;coronavirus using quantitative RT&#x02010;PCR with dual systems</article-title>. <source xml:lang="en">J Med Virol</source>. <year>2005</year>;<volume>77</volume>(<issue>2</issue>):<fpage>151</fpage>&#x02010;<lpage>158</lpage>.<pub-id pub-id-type="pmid">16121372</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="rmv2106-cit-0061">
<string-name>
<surname>Houng</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Norwood</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ludwig</surname>
<given-names>GV</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vaughn</surname>
<given-names>DW</given-names>
</string-name>. <article-title>Development and evaluation of an efficient 3&#x02032;&#x02010;noncoding region based SARS coronavirus (SARS&#x02010;CoV) RT&#x02010;PCR assay for detection of SARS&#x02010;CoV infections</article-title>. <source xml:lang="en">J Virol Methods</source>. <year>2004</year>;<volume>120</volume>(<issue>1</issue>):<fpage>33</fpage>&#x02010;<lpage>40</lpage>.<pub-id pub-id-type="pmid">15234807</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0062"><label>62</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0062">
<collab collab-type="authors">WHO</collab>
. Laboratory Testing for Middle East Respiratory Syndrome Coronavirus. <year>2018</year>.</mixed-citation></ref><ref id="rmv2106-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="rmv2106-cit-0063">
<string-name>
<surname>Corman</surname>
<given-names>VM</given-names>
</string-name>, <string-name>
<surname>Eckerle</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bleicker</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Detection of a novel human coronavirus by real&#x02010;time reverse&#x02010;transcription polymerase chain reaction</article-title>. <source xml:lang="en">Euro Surveill</source>. <year>2012</year>;<volume>17</volume>(<issue>39</issue>):pii/20285.</mixed-citation></ref><ref id="rmv2106-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="rmv2106-cit-0064">
<string-name>
<surname>Corman</surname>
<given-names>VM</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Costabel</surname>
<given-names>U</given-names>
</string-name>, et al. <article-title>Assays for laboratory confirmation of novel human coronavirus (hCoV&#x02010;EMC) infections</article-title>. <source xml:lang="en">Euro Surveill</source>. <year>2012</year>;<volume>17</volume>(<issue>49</issue>):pii/20334.</mixed-citation></ref><ref id="rmv2106-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="rmv2106-cit-0065">
<string-name>
<surname>Lu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Whitaker</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Sakthivel</surname>
<given-names>SK</given-names>
</string-name>, et al. <article-title>Real&#x02010;time reverse transcription&#x02010;PCR assay panel for Middle East respiratory syndrome coronavirus</article-title>. <source xml:lang="en">J Clin Microbiol</source>. <year>2014</year>;<volume>52</volume>(<issue>1</issue>):<fpage>67</fpage>&#x02010;<lpage>75</lpage>.<pub-id pub-id-type="pmid">24153118</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="rmv2106-cit-0066">
<string-name>
<surname>Simons</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Vennema</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Rofina</surname>
<given-names>JE</given-names>
</string-name>, et al. <article-title>A mRNA PCR for the diagnosis of feline infectious peritonitis</article-title>. <source xml:lang="en">J Virol Methods</source>. <year>2005</year>;<volume>124</volume>(<issue>1&#x02013;2</issue>):<fpage>111</fpage>&#x02010;<lpage>116</lpage>.<pub-id pub-id-type="pmid">15664058</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="rmv2106-cit-0067">
<string-name>
<surname>Corman</surname>
<given-names>VM</given-names>
</string-name>, <string-name>
<surname>Landt</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Kaiser</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Detection of 2019 novel coronavirus (2019&#x02010;nCoV) by real&#x02010;time RT&#x02010;PCR</article-title>. <source xml:lang="en">Euro Surveill</source>. <year>2020</year>;<volume>25</volume>(<issue>3</issue>):2000045.</mixed-citation></ref><ref id="rmv2106-bib-0068"><label>68</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0068">
<string-name>
<surname>Chinese</surname>
<given-names>CDC</given-names>
</string-name>. Specific primers and probes for detection 2019 novel coronavirus. <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0069"><label>69</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0069">
<collab collab-type="authors">HKU</collab>
. Detection of 2019 novel coronavirus (2019&#x02010;nCoV) in suspected human cases by RT&#x02010;PCR. <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0070"><label>70</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0070">
<collab collab-type="authors">Thailand Ministry of Public Health</collab>
. Diagnostic detection of Novel coronavirus 2019 by real time RTPCR. <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0071"><label>71</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0071">Japanese National Institute of Infectious Diseases. PCR and sequencing protocols for 2019&#x02010;nCoV. <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0072"><label>72</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0072">
<collab collab-type="authors">US CDC</collab>
. Real&#x02010;Time RT&#x02010;PCR Panel for Detection 2019&#x02010;Novel Coronavirus. <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0073"><label>73</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0073">
<collab collab-type="authors">National Health Commission of China</collab>
. Guideline for laboratory testing of COVID&#x02010;19.</mixed-citation></ref><ref id="rmv2106-bib-0074"><label>74</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0074">
<collab collab-type="authors">US CDC</collab>
. CDC 2019&#x02010;novel cornoavirus real&#x02010;time RT&#x02010;PCR diagnostic panel. <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="rmv2106-cit-0075">
<string-name>
<surname>Kim</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Easley</surname>
<given-names>CJ</given-names>
</string-name>. <article-title>Isothermal DNA amplification in bioanalysis: strategies and applications</article-title>. <source xml:lang="en">Bioanalysis</source>. <year>2011</year>;<volume>3</volume>(<issue>2</issue>):<fpage>227</fpage>&#x02010;<lpage>239</lpage>.<pub-id pub-id-type="pmid">21250850</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="rmv2106-cit-0076">
<string-name>
<surname>Vincent</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kong</surname>
<given-names>H</given-names>
</string-name>. <article-title>Helicase&#x02010;dependent isothermal DNA amplification</article-title>. <source xml:lang="en">EMBO Rep</source>. <year>2004</year>;<volume>5</volume>(<issue>8</issue>):<fpage>795</fpage>&#x02010;<lpage>800</lpage>.<pub-id pub-id-type="pmid">15247927</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="rmv2106-cit-0077">
<string-name>
<surname>Piepenburg</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Stemple</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Armes</surname>
<given-names>NA</given-names>
</string-name>. <article-title>DNA detection using recombination proteins</article-title>. <source xml:lang="en">PLoS Biol</source>. <year>2006</year>;<volume>4</volume>(<issue>7</issue>):<elocation-id>e204</elocation-id>.<pub-id pub-id-type="pmid">16756388</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="rmv2106-cit-0078">
<string-name>
<surname>Leone</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>van Schijndel</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>van Gemen</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Kramer</surname>
<given-names>FR</given-names>
</string-name>, <string-name>
<surname>Schoen</surname>
<given-names>CD</given-names>
</string-name>. <article-title>Molecular beacon probes combined with amplification by NASBA enable homogeneous, real&#x02010;time detection of RNA</article-title>. <source xml:lang="en">Nucleic Acids Res</source>. <year>1998</year>;<volume>26</volume>(<issue>9</issue>):<fpage>2150</fpage>&#x02010;<lpage>2155</lpage>.<pub-id pub-id-type="pmid">9547273</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="rmv2106-cit-0079">
<string-name>
<surname>Nilsson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gullberg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dahl</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Szuhai</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Raap</surname>
<given-names>AK</given-names>
</string-name>. <article-title>Real&#x02010;time monitoring of rolling&#x02010;circle amplification using a modified molecular beacon design</article-title>. <source xml:lang="en">Nucleic Acids Res</source>. <year>2002</year>;<volume>30</volume>(<issue>14</issue>):<elocation-id>e66</elocation-id>.<pub-id pub-id-type="pmid">12136114</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="rmv2106-cit-0080">
<string-name>
<surname>Euler</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Heidenreich</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Development of a panel of recombinase polymerase amplification assays for detection of biothreat agents</article-title>. <source xml:lang="en">J Clin Microbiol</source>. <year>2013</year>;<volume>51</volume>(<issue>4</issue>):<fpage>1110</fpage>&#x02010;<lpage>1117</lpage>.<pub-id pub-id-type="pmid">23345286</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="rmv2106-cit-0081">
<string-name>
<surname>Notomi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Okayama</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Masubuchi</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Loop&#x02010;mediated isothermal amplification of DNA</article-title>. <source xml:lang="en">Nucleic Acids Res</source>. <year>2000</year>;<volume>28</volume>(<issue>12</issue>):<elocation-id>E63</elocation-id>.<pub-id pub-id-type="pmid">10871386</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="rmv2106-cit-0082">
<string-name>
<surname>Parida</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sannarangaiah</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dash</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Rao</surname>
<given-names>PV</given-names>
</string-name>, <string-name>
<surname>Morita</surname>
<given-names>K</given-names>
</string-name>. <article-title>Loop mediated isothermal amplification (LAMP): a new generation of innovative gene amplification technique; perspectives in clinical diagnosis of infectious diseases</article-title>. <source xml:lang="en">Rev Med Virol</source>. <year>2008</year>;<volume>18</volume>(<issue>6</issue>):<fpage>407</fpage>&#x02010;<lpage>421</lpage>.<pub-id pub-id-type="pmid">18716992</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="rmv2106-cit-0083">
<string-name>
<surname>Chantratita</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Pongtanapisit</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Piroj</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Srichunrasmi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Seesuai</surname>
<given-names>S</given-names>
</string-name>. <article-title>Development and comparison of the real&#x02010;time amplification based methods&#x02014;NASBA&#x02010;Beacon, RT&#x02010;PCR taqman and RT&#x02010;PCR hybridization probe assays&#x02014;for the qualitative detection of sars coronavirus</article-title>. <source xml:lang="en">Southeast Asian J Trop Med Public Health</source>. <year>2004</year>;<volume>35</volume>(<issue>3</issue>):<fpage>623</fpage>&#x02010;<lpage>629</lpage>.<pub-id pub-id-type="pmid">15689078</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="rmv2106-cit-0084">
<string-name>
<surname>Hong</surname>
<given-names>TC</given-names>
</string-name>, <string-name>
<surname>Mai</surname>
<given-names>QL</given-names>
</string-name>, <string-name>
<surname>Cuong</surname>
<given-names>DV</given-names>
</string-name>, et al. <article-title>Development and evaluation of a novel loop&#x02010;mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus</article-title>. <source xml:lang="en">J Clin Microbiol</source>. <year>2004</year>;<volume>42</volume>(<issue>5</issue>):<fpage>1956</fpage>&#x02010;<lpage>1961</lpage>.<pub-id pub-id-type="pmid">15131154</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="rmv2106-cit-0085">
<string-name>
<surname>Poon</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>BW</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>KH</given-names>
</string-name>, et al. <article-title>Evaluation of real&#x02010;time reverse transcriptase PCR and real&#x02010;time loop&#x02010;mediated amplification assays for severe acute respiratory syndrome coronavirus detection</article-title>. <source xml:lang="en">J Clin Microbiol</source>. <year>2005</year>;<volume>43</volume>(<issue>7</issue>):<fpage>3457</fpage>&#x02010;<lpage>3459</lpage>.<pub-id pub-id-type="pmid">16000477</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="rmv2106-cit-0086">
<string-name>
<surname>Wang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Potter</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Rapid and sensitive detection of severe acute respiratory syndrome coronavirus by rolling circle amplification</article-title>. <source xml:lang="en">J Clin Microbiol</source>. <year>2005</year>;<volume>43</volume>(<issue>5</issue>):<fpage>2339</fpage>&#x02010;<lpage>2344</lpage>.<pub-id pub-id-type="pmid">15872263</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="rmv2106-cit-0087">
<string-name>
<surname>Abd El Wahed</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Heidenreich</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hufert</surname>
<given-names>FT</given-names>
</string-name>, <string-name>
<surname>Weidmann</surname>
<given-names>M</given-names>
</string-name>. <article-title>Reverse transcription recombinase polymerase amplification assay for the detection of Middle East respiratory syndrome coronavirus</article-title>. <source xml:lang="en">PLoS Curr</source>. <year>2013</year>;<volume>5</volume>
<pub-id pub-id-type="doi">10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364</pub-id>
</mixed-citation></ref><ref id="rmv2106-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="rmv2106-cit-0088">
<string-name>
<surname>Shirato</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Semba</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>El&#x02010;Kafrawy</surname>
<given-names>SA</given-names>
</string-name>, et al. <article-title>Development of fluorescent reverse transcription loop&#x02010;mediated isothermal amplification (RT&#x02010;LAMP) using quenching probes for the detection of the Middle East respiratory syndrome coronavirus</article-title>. <source xml:lang="en">J Virol Methods</source>. <year>2018</year>;<volume>258</volume>:<fpage>41</fpage>&#x02010;<lpage>48</lpage>.<pub-id pub-id-type="pmid">29763640</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="rmv2106-cit-0089">
<string-name>
<surname>Li</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Nie</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Detection of Middle East respiratory syndrome coronavirus by reverse&#x02010;transcription loop&#x02010;mediated isothermal amplification</article-title>. <source xml:lang="en">Bing Du Xue Bao</source>. <year>2015</year>;<volume>31</volume>(<issue>3</issue>):<fpage>269</fpage>&#x02010;<lpage>275</lpage>.<pub-id pub-id-type="pmid">26470533</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="rmv2106-cit-0090">
<string-name>
<surname>Shirato</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yano</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Senba</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop&#x02010;mediated isothermal amplification (RT&#x02010;LAMP)</article-title>. <source xml:lang="en">Virol J</source>. <year>2014</year>;<volume>11</volume>:<fpage>139</fpage>.<pub-id pub-id-type="pmid">25103205</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="rmv2106-cit-0091">
<string-name>
<surname>Huang</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>Z</given-names>
</string-name>, et al. <article-title>A rapid and specific assay for the detection of MERS&#x02010;CoV</article-title>. <source xml:lang="en">Front Microbiol</source>. <year>2018</year>;<volume>9</volume>:<fpage>1101</fpage>.<pub-id pub-id-type="pmid">29896174</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="rmv2106-cit-0092">
<string-name>
<surname>Bhadra</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>RF</given-names>
</string-name>, <string-name>
<surname>Hensley</surname>
<given-names>LE</given-names>
</string-name>, <string-name>
<surname>Ellington</surname>
<given-names>AD</given-names>
</string-name>. <article-title>Real&#x02010;time sequence&#x02010;validated loop&#x02010;mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS&#x02010;CoV)</article-title>. <source xml:lang="en">PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>4</issue>):<elocation-id>e0123126</elocation-id>.<pub-id pub-id-type="pmid">25856093</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="rmv2106-cit-0093">
<string-name>
<surname>Lee</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Baek</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>YK</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Ahn</surname>
<given-names>JY</given-names>
</string-name>. <article-title>One&#x02010;pot reverse transcriptional loop&#x02010;mediated isothermal amplification (RT&#x02010;LAMP) for detecting MERS&#x02010;CoV</article-title>. <source xml:lang="en">Front Microbiol</source>. <year>2016</year>;<volume>7</volume>:<fpage>2166</fpage>.<pub-id pub-id-type="pmid">28119682</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="rmv2106-cit-0094">
<string-name>
<surname>Jansen</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Embden</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Gaastra</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Schouls</surname>
<given-names>LM</given-names>
</string-name>. <article-title>Identification of genes that are associated with DNA repeats in prokaryotes</article-title>. <source xml:lang="en">Mol Microbiol</source>. <year>2002</year>;<volume>43</volume>(<issue>6</issue>):<fpage>1565</fpage>&#x02010;<lpage>1575</lpage>.<pub-id pub-id-type="pmid">11952905</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="rmv2106-cit-0095">
<string-name>
<surname>Shalem</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Sanjana</surname>
<given-names>NE</given-names>
</string-name>, <string-name>
<surname>Hartenian</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Genome&#x02010;scale CRISPR&#x02010;Cas9 knockout screening in human cells</article-title>. <source xml:lang="en">Science</source>. <year>2014</year>;<volume>343</volume>(<issue>6166</issue>):<fpage>84</fpage>&#x02010;<lpage>87</lpage>.<pub-id pub-id-type="pmid">24336571</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0096"><label>96</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0096">
<string-name>
<surname>Feng Zhang</surname>
<given-names>OOA</given-names>
</string-name>, <string-name>
<surname>Jonathan</surname>
<given-names>S</given-names>
</string-name>. <article-title>Gootenberg. A protocol for detection of COVID&#x02010;19 using CRISPR diagnostics</article-title>. <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0097"><label>97</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0097">
<collab collab-type="authors">WHO</collab>
. Recommendations for laboratories testing by PCR for presence of SARS coronavirus&#x02010;RNA. <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="rmv2106-cit-0098">
<string-name>
<surname>Park</surname>
<given-names>WB</given-names>
</string-name>, <string-name>
<surname>Perera</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Choe</surname>
<given-names>PG</given-names>
</string-name>, et al. <article-title>Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea</article-title>. <source xml:lang="en">Emerg Infect Dis</source>. <year>2015</year>;<volume>21</volume>(<issue>12</issue>):<fpage>2186</fpage>&#x02010;<lpage>2189</lpage>.<pub-id pub-id-type="pmid">26583829</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0099"><label>99</label><mixed-citation publication-type="journal" id="rmv2106-cit-0099">
<string-name>
<surname>Meyer</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Drosten</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Serological assays for emerging coronaviruses: challenges and pitfalls</article-title>. <source xml:lang="en">Virus Res</source>. <year>2014</year>;<volume>194</volume>:<fpage>175</fpage>&#x02010;<lpage>183</lpage>.<pub-id pub-id-type="pmid">24670324</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0100"><label>100</label><mixed-citation publication-type="journal" id="rmv2106-cit-0100">
<string-name>
<surname>Chan</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Sridhar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yip</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Woo</surname>
<given-names>PC</given-names>
</string-name>. <article-title>The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic</article-title>. <source xml:lang="en">J Microbiol</source>. <year>2017</year>;<volume>55</volume>(<issue>3</issue>):<fpage>172</fpage>&#x02010;<lpage>182</lpage>.<pub-id pub-id-type="pmid">28243939</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0101"><label>101</label><mixed-citation publication-type="journal" id="rmv2106-cit-0101">
<string-name>
<surname>Qiu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>Z</given-names>
</string-name>, et al. <article-title>Antibody responses to individual proteins of SARS coronavirus and their neutralization activities</article-title>. <source xml:lang="en">Microbes Infect</source>. <year>2005</year>;<volume>7</volume>(<issue>5&#x02013;6</issue>):<fpage>882</fpage>&#x02010;<lpage>889</lpage>.<pub-id pub-id-type="pmid">15878679</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0102"><label>102</label><mixed-citation publication-type="journal" id="rmv2106-cit-0102">
<string-name>
<surname>Tan</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Goh</surname>
<given-names>PY</given-names>
</string-name>, <string-name>
<surname>Fielding</surname>
<given-names>BC</given-names>
</string-name>, et al. <article-title>Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers</article-title>. <source xml:lang="en">Clin Diagn Lab Immunol</source>. <year>2004</year>;<volume>11</volume>(<issue>2</issue>):<fpage>362</fpage>&#x02010;<lpage>371</lpage>.<pub-id pub-id-type="pmid">15013989</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0103"><label>103</label><mixed-citation publication-type="journal" id="rmv2106-cit-0103">
<string-name>
<surname>Woo</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>BH</given-names>
</string-name>, et al. <article-title>Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme&#x02010;linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia</article-title>. <source xml:lang="en">J Clin Microbiol</source>. <year>2005</year>;<volume>43</volume>(<issue>7</issue>):<fpage>3054</fpage>&#x02010;<lpage>3058</lpage>.<pub-id pub-id-type="pmid">16000415</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0104"><label>104</label><mixed-citation publication-type="journal" id="rmv2106-cit-0104">
<string-name>
<surname>Vlasova</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Hasoksuz</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Two&#x02010;way antigenic cross&#x02010;reactivity between severe acute respiratory syndrome coronavirus (SARS&#x02010;CoV) and group 1 animal CoVs is mediated through an antigenic site in the N&#x02010;terminal region of the SARS&#x02010;CoV nucleoprotein</article-title>. <source xml:lang="en">J Virol</source>. <year>2007</year>;<volume>81</volume>(<issue>24</issue>):<fpage>13365</fpage>&#x02010;<lpage>13377</lpage>.<pub-id pub-id-type="pmid">17913799</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0105"><label>105</label><mixed-citation publication-type="journal" id="rmv2106-cit-0105">
<string-name>
<surname>Chan</surname>
<given-names>KH</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Tse</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Cross&#x02010;reactive antibodies in convalescent SARS patients&#x02019; sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests</article-title>. <source xml:lang="en">J Infect</source>. <year>2013</year>;<volume>67</volume>(<issue>2</issue>):<fpage>130</fpage>&#x02010;<lpage>140</lpage>.<pub-id pub-id-type="pmid">23583636</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0106"><label>106</label><mixed-citation publication-type="journal" id="rmv2106-cit-0106">
<string-name>
<surname>Elshabrawy</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Coughlin</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Prabhakar</surname>
<given-names>BS</given-names>
</string-name>. <article-title>Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS&#x02010;CoV spike protein are more broadly neutralizing</article-title>. <source xml:lang="en">PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>11</issue>):<elocation-id>e50366</elocation-id>.<pub-id pub-id-type="pmid">23185609</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0107"><label>107</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0107">
<collab collab-type="authors">WHO</collab>
. Severe Acute Respiratory Syndrome (SARS): laboratory diagnostic tests. <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0108"><label>108</label><mixed-citation publication-type="miscellaneous" id="rmv2106-cit-0108">
<collab collab-type="authors">US CDC</collab>
. CDC laboratory testing for Middle East respiratory syndrome coronavirus (MERS&#x02010;CoV). <year>2020</year>.</mixed-citation></ref><ref id="rmv2106-bib-0109"><label>109</label><mixed-citation publication-type="journal" id="rmv2106-cit-0109">
<string-name>
<surname>Wang</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>XL</given-names>
</string-name>, et al. <article-title>Serological evidence of bat SARS&#x02010;related coronavirus infection in humans, China</article-title>. <source xml:lang="en">Virol Sin</source>. <year>2018</year>;<volume>33</volume>(<issue>1</issue>):<fpage>104</fpage>&#x02010;<lpage>107</lpage>.<pub-id pub-id-type="pmid">29500691</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0110"><label>110</label><mixed-citation publication-type="journal" id="rmv2106-cit-0110">
<string-name>
<surname>Zou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ruan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>SARS&#x02010;CoV&#x02010;2 viral load in upper respiratory specimens of infected patients</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2020</year>;<volume>382</volume>:<fpage>1177</fpage>&#x02010;<lpage>1179</lpage>.<pub-id pub-id-type="pmid">32074444</pub-id></mixed-citation></ref><ref id="rmv2106-bib-0111"><label>111</label><mixed-citation publication-type="journal" id="rmv2106-cit-0111">
<string-name>
<surname>Holshue</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>DeBolt</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lindquist</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>First case of 2019 novel coronavirus in the United States</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2020</year>;<volume>382</volume>(10):929&#x02010;936.</mixed-citation></ref><ref id="rmv2106-bib-0112"><label>112</label><mixed-citation publication-type="journal" id="rmv2106-cit-0112">
<string-name>
<surname>Young</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>Ong</surname>
<given-names>SWX</given-names>
</string-name>, <string-name>
<surname>Kalimuddin</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Epidemiologic features and clinical course of patients infected with SARS&#x02010;CoV&#x02010;2 in Singapore</article-title>. <source xml:lang="en">JAMA</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1001/jama.2020.3204</pub-id>
</mixed-citation></ref></ref-list></back></article>